These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended
June 30, 2025
or
☐
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______ to _______
Commission File Number:
001-36777
JAMES RIVER GROUP HOLDINGS, LTD.
(Exact name of registrant as specified in its charter)
Bermuda
98-0585280
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
Clarendon House
,
2 Church Street
,
Hamilton
,
Pembroke
HM11
,
Bermuda
(Address of principal executive offices)
(Zip Code)
(
441
)
295-1422
(Registrant
'
s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Names of each exchange on which registered
Common Shares, par value $0.0002 per share
JRVR
NASDAQ
Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
x
No
¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
x
No
¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
x
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
x
Number of shares of the registrant's common shares outstanding at July 31, 2025:
45,916,453
This Quarterly Report on Form 10-Q, or Quarterly Report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may be identified by the fact that they do not relate strictly to historical or current facts. You may identify forward-looking statements in this Quarterly Report by the use of words such as “anticipates,” “estimates,” “expects,” “intends,” “plans”, “seeks” and “believes,” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could.” These forward-looking statements include, among others, all statements relating to our future financial performance, our business prospects and strategy, anticipated financial position and financial strength ratings, liquidity and capital needs and other similar matters. These forward-looking statements are based on management’s current expectations and assumptions about future events, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict.
Our actual results may differ materially from those expressed in, or implied by, the forward-looking statements included in this Quarterly Report as a result of various factors, many of which are beyond our control, including, among others:
•
the inherent uncertainty of estimating reserves and the possibility that incurred losses may be greater than our estimate used to compute loss and loss adjustment expense reserves;
•
inaccurate estimates and judgments in our risk management may expose us to greater risks than intended;
•
downgrades in the financial strength rating or outlook of our regulated insurance subsidiaries impacting our competitive position and ability to attract and retain insurance business that our subsidiaries write and ultimately our financial condition;
•
the outcome of the litigation in connection with the sale of our casualty reinsurance business;
•
the potential loss of key members of our management team or key employees, and our ability to attract and retain personnel;
•
adverse economic and competitive factors resulting in the sale of fewer policies than expected or an increase in the frequency or severity of claims, or both;
•
the impact of a higher than expected inflationary environment on our reserves, loss adjustment expenses, the values of our investments and investment returns, and our compensation expenses;
•
exposure to credit risk, interest rate risk and other market risk in our investment portfolio and our reinsurers;
•
reliance on a select group of brokers and agents for a significant portion of our business and the impact of our potential failure to maintain such relationships;
•
reliance on a select group of customers for a significant portion of our business and the impact of our potential failure to maintain, or decision to terminate, such relationships;
•
our ability to obtain insurance and reinsurance coverage at prices and on terms that allow us to transfer risk, adequately protect our Company against financial loss and that supports our growth plans;
•
losses resulting from reinsurance counterparties failing to pay us on reinsurance claims, insurance companies with whom we have a fronting arrangement failing to pay us for claims, or a former customer with whom we have an indemnification arrangement failing to perform its reimbursement obligations, and our potential inability to demand or maintain adequate collateral to mitigate such risks;
•
the inherent uncertainty of estimating reinsurance recoverable on unpaid losses and the possibility that reinsurance may be less than our estimate of reinsurance recoverable on unpaid losses;
•
inadequacy of premiums we charge to compensate us for our losses incurred;
•
changes in laws or government regulation, including tax or insurance laws and regulations;
•
changes in U.S. tax laws (including associated regulations) and the interpretation of certain provisions applicable to insurance/reinsurance businesses with U.S. and non-U.S. operations, which may be retroactive and could have a significant effect on us including, among other things, by potentially increasing our tax rate, as well as on our shareholders;
3
•
in the event we did not qualify for the insurance company exception to the passive foreign investment company (“PFIC”) rules and were therefore considered a PFIC, there could be material adverse tax consequences to an investor that is subject to U.S. federal income taxation;
•
the Company or its foreign subsidiary becoming subject to U.S. federal income taxation;
•
a failure of any of the loss limitations or exclusions we utilize in our insurance products to shield us from unanticipated financial losses or legal exposures, or other liabilities;
•
losses from catastrophic events, such as natural disasters and terrorist acts, which substantially exceed our expectations and/or exceed the amount of reinsurance we have purchased to protect us from such events;
•
potential effects on our business of emerging claim and coverage issues;
•
the potential impact of internal or external fraud, operational errors, systems malfunctions or cyber security incidents;
•
our ability to manage our growth effectively;
•
failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act of 2002, as amended;
•
changes in our financial condition, regulations or other factors that may restrict our subsidiaries’ ability to pay us dividends;
•
an adverse result in any litigation or legal proceedings we are or may become subject to; and
•
other risks and uncertainties discussed in this Quarterly Report.
Accordingly, you should read this Quarterly Report completely and with the understanding that our actual future results may be materially different from information contained in the forward-looking statements.
Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those in the forward-looking statements, is contained in our filings with the U.S. Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 4, 2025.
Forward-looking statements speak only as of the date of this Quarterly Report. Except as expressly required under federal securities laws and the rules and regulations of the SEC, we do not have any obligation, and do not undertake, to update any forward-looking statements to reflect events or circumstances arising after the date of this Quarterly Report, whether as a result of new information or future events or otherwise. You should not place undue reliance on the forward-looking statements included in this Quarterly Report or that may be made elsewhere from time to time by us, or on our behalf. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.
Series A redeemable preferred shares – 2025 and 2024:
165,000
shares authorized;
112,500
shares issued and outstanding
133,115
133,115
Shareholders’ equity:
Common shares – 2025 and 2024: $
0.0002
par value;
200,000,000
shares authorized;
45,895,335
and
45,644,318
shares issued and outstanding, respectively
9
9
Preferred Shares – 2025 and 2024: $
0.00125
par value;
19,835,000
shares authorized;
no
shares issued and outstanding
—
—
Additional paid-in capital
936,255
933,311
Retained deficit
(
392,958
)
(
402,408
)
Accumulated other comprehensive loss
(
50,748
)
(
69,997
)
Total shareholders’ equity
492,558
460,915
Total liabilities, Series A redeemable preferred shares, and shareholders’ equity
Condensed Consolidated Statements of Cash Flows (Unaudited)
Six Months Ended June 30,
2025
2024
(in thousands)
Operating activities
Net cash (used in) provided by operating activities (a)
$
(
26,310
)
$
15,397
Investing activities
Sale of JRG Re
—
96,412
Fixed maturity securities, available-for-sale:
Purchases
(
148,956
)
(
28,727
)
Sales
7,616
198,046
Maturities and calls
55,891
84,596
Equity securities:
Purchases
(
6,111
)
(
7,311
)
Sales and redemptions
4,940
6,190
Bank loan participations:
Purchases
(
79,526
)
(
80,700
)
Sales
45,234
51,913
Maturities
16,121
19,252
Other invested assets:
Purchases
(
21,718
)
(
4,725
)
Return of capital
600
472
Proceeds from sales and principal repayments
322
2,763
Short-term investments, net
(
14,142
)
26,160
Securities receivable or payable, net
7,707
(
6,386
)
Purchases of property and equipment
(
1,677
)
(
1,327
)
Net cash (used in) provided by investing activities
(
133,699
)
356,628
Financing activities
Senior debt issuances
25,000
—
Senior debt repayments
—
(
21,500
)
Payroll taxes withheld and remitted on net settlement of RSUs
(
550
)
(
837
)
Dividends on Series A preferred shares
(
3,938
)
(
5,250
)
Dividends on common shares
(
1,061
)
(
3,901
)
Payment of debt issuance costs
(
1,130
)
—
Net cash provided by (used in) financing activities
18,321
(
31,488
)
Change in cash, cash equivalents, and restricted cash equivalents
(
141,688
)
340,537
Cash, cash equivalents, and restricted cash equivalents at beginning of period
391,050
359,949
Cash, cash equivalents, and restricted cash equivalents at end of period
$
249,362
$
700,486
Supplemental information
Interest paid
$
11,694
$
15,628
Restricted cash equivalents at beginning of period
$
28,705
$
72,449
Restricted cash equivalents at end of period
$
29,321
$
27,963
Change in restricted cash equivalents
$
616
$
(
44,486
)
(a)
Cash provided by operating activities for the six months ended June 30, 2025 and 2024 includes the restricted cash activity above related to a former insured, per the terms of a collateral trust. See “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations –
Amounts Recoverable from an Indemnifying Party and Reinsurer on Legacy Commercial Auto Book
”. Excluding the restricted cash activity, cash (used in) provided by operating activities was $(
26.9
) million and $
59.9
million for the six months ended June 30, 2025 and 2024, respectively.
Notes to Condensed Consolidated Financial Statements
1.
Accounting Policies
Organization
James River Group Holdings, Ltd. (referred to as “JRG Holdings” or, with its subsidiaries, the “Company”) is an exempted holding company registered in Bermuda, organized for the purpose of acquiring and managing insurance entities.
The Company owns
five
insurance companies based in the United States (“U.S.”) focused on specialty insurance niches as described below:
•
James River Group Holdings UK Limited (“James River UK”) is an insurance holding company formed in 2015 in the United Kingdom (“U.K.”). JRG Holdings contributed James River Group, Inc. (“James River Group”), a U.S. insurance holding company, to James River UK in 2015.
•
James River Group is a Delaware domiciled insurance holding company formed in 2002 which owns all of the Company’s U.S.-based subsidiaries, either directly or indirectly through one of its wholly-owned U.S. subsidiaries. James River Group oversees the Company’s U.S. insurance operations and maintains all of the outstanding debt in the U.S.
•
James River Insurance Company is an Ohio domiciled excess and surplus lines insurance company that, with its wholly-owned insurance subsidiary, James River Casualty Company, an Ohio domiciled company, is authorized to write business in every state and the District of Columbia.
•
Falls Lake National Insurance Company (“Falls Lake National”) is an Ohio domiciled insurance company which wholly owns Stonewood Insurance Company, an Ohio domiciled company, and Falls Lake Fire and Casualty Company, a California domiciled company. Falls Lake National and its subsidiaries primarily write specialty admitted fronting and program business.
The Company previously owned JRG Reinsurance Company Ltd. (“JRG Re”), a Bermuda domiciled reinsurer, which comprised the former Casualty Reinsurance segment, and which, prior to the suspension of its underwriting activities in 2023, primarily provided non-catastrophe casualty reinsurance to U.S. third parties. On November 8, 2023, the Company entered into an agreement to sell JRG Re. The sale closed on April 16, 2024 and resulted in the Company’s disposition of its casualty reinsurance business and related assets. The Company has no continued involvement with JRG Re following the sale. See Discontinued Operations below and Note 2 for additional disclosure.
Basis of Presentation
The accompanying condensed consolidated financial statements and notes have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and do not contain all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements include the results of the Company and its subsidiaries from their respective dates of inception or acquisition, as applicable. Readers are urged to review the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 for a more complete description of the Company’s business and accounting policies. In the opinion of management, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2024 was derived from the Company’s audited annual consolidated financial statements.
Intercompany transactions and balances have been eliminated.
Discontinued Operations
The results of operations of a component of the Company are reported in discontinued operations when certain criteria are met as of the date of disposal, or earlier if classified as held-for-sale. The Company determined that the sale of JRG Re, which closed on April 16, 2024, represented a strategic shift that will have a major effect on the Company's operations. Accordingly, the results of JRG Re's operations have been presented as discontinued operations for all periods presented in this interim report on Form 10-Q.
See Note 2 for additional disclosure.
Estimates and Assumptions
Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and
Notes to Condensed Consolidated Financial Statements (continued)
accompanying disclosures. Those estimates are inherently subject to change, and actual results may ultimately differ from those estimates.
Variable Interest Entities
Entities that do not have sufficient equity at risk to allow the entity to finance its activities without additional financial support or in which the equity investors, as a group, do not have the characteristic of a controlling financial interest are referred to as variable interest entities (“VIE”). A VIE is consolidated by the variable interest holder that is determined to have the controlling financial interest (primary beneficiary) as a result of having both the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company determines whether it is the primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE’s capital structure, contractual terms, nature of the VIE’s operations and purpose, and the Company’s relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE. The Company reassesses its VIE determination with respect to an entity on an ongoing basis.
The Company holds interests in VIEs through certain equity method investments included in “other invested assets” in the accompanying condensed consolidated balance sheets. The Company has determined that it should not consolidate any of the VIEs as it is not the primary beneficiary in any of the relationships. Although the investments resulted in the Company holding variable interests in the entities, they did not empower the Company to direct the activities that most significantly impact the economic performance of the entities.
The Company’s investments related to these VIEs totaled $
7.3
million at June 30, 2025 and $
7.7
million at December 31, 2024, representing the Company’s maximum exposure to loss.
Income Tax Expense
Our effective tax rate fluctuates from period to period based on the relative mix of income from continuing operations reported by country and the respective tax rates imposed by each tax jurisdiction. Statutory tax rates are 0% and 21% for Bermuda and the U.S.
For the three and six months ended June 30, 2025, our effective tax rate on income from continuing operations was
30.1
% and
31.0
%, respectively (
28.3
% and
28.5
% in the respective prior year periods). The Company does not receive a U.S. tax deduction for losses in our Bermuda entities. Bermuda had losses in both periods primarily due to Bermuda holding company expenses and interest expense. For U.S.-sourced income, the Company’s U.S. federal income tax expense differs from the amounts computed by applying the federal statutory income tax rate to income before taxes due primarily to interest income on tax-advantaged state and municipal securities, dividends received income, and excess tax benefits and expenses on share based compensation.
Adopted Accounting Standards
There were no new accounting standards adopted in 2025 that materially impacted the Company's financial statements.
Prospective Accounting Standards
The guidance in ASU 2023-09
—Income Taxes (Topic 740): Improvements to Income Tax Disclosures
was designed to increase transparency about income tax information through improvements to the rate reconciliation and disclosure of income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024. Although the Company continues to evaluate the impact of adopting this new accounting standard, the amendments are disclosure-related and are not expected to have a material impact on the Company's financial statements.
The guidance in ASU 2024-03
, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses
requires additional, disaggregated disclosure around certain income statement expense line items. This ASU is effective for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, although early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on the disclosures in its financial statements.
Notes to Condensed Consolidated Financial Statements (continued)
2.
Discontinued Operations
On November 8, 2023, the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Fleming Intermediate Holdings LLC, a Cayman Islands limited liability company (“Fleming”). Pursuant to the Stock Purchase Agreement, and on the terms and subject to the conditions therein, Fleming agreed to purchase from the Company all of the common shares of JRG Re. JRG Re comprised the remaining operations of the former Casualty Reinsurance segment, and the sale of JRG Re, which closed on April 16, 2024, resulted in the Company’s disposition of its casualty reinsurance business and related assets.
Pursuant to the terms of the Stock Purchase Agreement, the aggregate consideration received by the Company, after giving effect to estimated adjustments based on changes in JRG Re’s adjusted net worth between March 31, 2023 and the closing, totaled approximately $
291.4
million (the “Closing Date Purchase Price”). The aggregate Closing Date Purchase Price was comprised of (i) $
152.4
million paid in cash by Fleming and (ii) an aggregate $
139.0
million dividend and distribution from contributed surplus by JRG Re to the Company. In accordance with the Stock Purchase Agreement, the cash portion of the purchase price was calculated based on an estimated balance sheet of JRG Re as of the date of closing. The estimated balance sheet was subject to final post-closing adjustments, which resulted in the downward adjustment to the cash portion of the Closing Date Purchase Price discussed below.
As required by the Stock Purchase Agreement, the Company and Fleming engaged in a post-closing purchase price true-up process. The Company agreed with an initial $
11.4
million downward adjustment to the Closing Date Purchase Price due to losses from JRG Re’s operations between the date of the balance sheet used to produce the estimated closing statement and the Closing Date, which downward adjustment was paid to Fleming on October 18, 2024. On April 18, 2025, the independent accounting firm appointed by the parties issued its final determination, concluding the post-closing purchase price true-up process. Pursuant to this final determination, the Company paid $
522,789
to Fleming on April 29, 2025 comprised of a $
483,625
final downward adjustment to the Closing Date Purchase Price and interest due according to terms of the Stock Purchase Agreement.
The Company determined that the sale of JRG Re represented a strategic shift that will have a major effect on its operations. Accordingly, the results of JRG Re's operations have been presented as discontinued operations for all periods presented in this interim report on Form 10-Q.
The $
139.0
million pre-closing dividend was completed in the first quarter of 2024. It included the forgiveness of $
133.2
million owed from JRG Holdings to JRG Re and $
5.8
million paid in cash to JRG Holdings. The loss on disposal for the six months ended June 30, 2024 of $
1.4
million includes a $
2.4
million gain for the change in the estimated loss on sale and selling costs incurred of $
3.8
million. For the six months ended June 30, 2025, the loss on disposal of $
1.8
million includes the $
522,789
downward adjustment to the Closing Date Purchase Price plus interest and $
1.3
million of additional selling costs incurred by the Company related to the sale of JRG Re.
Notes to Condensed Consolidated Financial Statements (continued)
3.
Investments
The Company’s available-for-sale fixed maturity securities are summarized as follows:
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
(in thousands)
June 30, 2025
Fixed maturity securities:
State and municipal
$
222,687
$
689
$
(
23,886
)
$
199,490
Residential mortgage-backed
415,523
1,071
(
19,484
)
397,110
Corporate
545,680
4,062
(
21,234
)
528,508
Commercial mortgage and asset-backed
162,123
181
(
5,487
)
156,817
U.S. Treasury securities and obligations guaranteed by the U.S. government
18,442
7
(
157
)
18,292
Total fixed maturity securities, available-for-sale
$
1,364,455
$
6,010
$
(
70,248
)
$
1,300,217
December 31, 2024
Fixed maturity securities:
State and municipal
$
223,009
$
598
$
(
27,043
)
$
196,564
Residential mortgage-backed
352,064
32
(
25,869
)
326,227
Corporate
503,610
1,358
(
29,483
)
475,485
Commercial mortgage and asset-backed
178,238
112
(
7,892
)
170,458
U.S. Treasury securities and obligations guaranteed by the U.S. government
21,416
2
(
419
)
20,999
Total fixed maturity securities, available-for-sale
$
1,278,337
$
2,102
$
(
90,706
)
$
1,189,733
The amortized cost and fair value of available-for-sale investments in fixed maturity securities at June 30, 2025 are summarized, by contractual maturity, as follows:
Cost or
Amortized
Cost
Fair
Value
(in thousands)
One year or less
$
31,869
$
31,588
After one year through five years
392,344
385,220
After five years through ten years
217,668
205,185
After ten years
144,928
124,297
Residential mortgage-backed
415,523
397,110
Commercial mortgage and asset-backed
162,123
156,817
Total
$
1,364,455
$
1,300,217
Actual maturities may differ for some securities because borrowers have the right to call or prepay obligations with or without penalties.
Notes to Condensed Consolidated Financial Statements (continued)
The following table shows the Company’s gross unrealized losses and fair value for available-for-sale securities aggregated by investment category and the length of time that individual securities have been in a continuous unrealized loss position:
Less Than 12 Months
12 Months or More
Total
Fair
Value
Gross
Unrealized
Losses
Fair
Value
Gross
Unrealized
Losses
Fair
Value
Gross
Unrealized
Losses
(in thousands)
June 30, 2025
Fixed maturity securities:
State and municipal
$
34,119
$
(
769
)
$
149,917
$
(
23,117
)
$
184,036
$
(
23,886
)
Residential mortgage-backed
146,323
(
2,555
)
136,998
(
16,929
)
283,321
(
19,484
)
Corporate
77,546
(
1,936
)
219,120
(
19,298
)
296,666
(
21,234
)
Commercial mortgage and asset-backed
17,317
(
11
)
94,438
(
5,476
)
111,755
(
5,487
)
U.S. Treasury securities and obligations guaranteed by the U.S. government
6,548
(
12
)
7,690
(
145
)
14,238
(
157
)
Total fixed maturity securities, available-for-sale
$
281,853
$
(
5,283
)
$
608,163
$
(
64,965
)
$
890,016
$
(
70,248
)
December 31, 2024
Fixed maturity securities:
State and municipal
$
35,979
$
(
1,087
)
$
146,547
$
(
25,956
)
$
182,526
$
(
27,043
)
Residential mortgage-backed
179,807
(
5,285
)
140,559
(
20,584
)
320,366
(
25,869
)
Corporate
149,149
(
4,281
)
220,743
(
25,202
)
369,892
(
29,483
)
Commercial mortgage and asset-backed
17,991
(
65
)
101,525
(
7,827
)
119,516
(
7,892
)
U.S. Treasury securities and obligations guaranteed by the U.S. government
7,653
(
115
)
12,412
(
304
)
20,065
(
419
)
Total fixed maturity securities, available-for-sale
$
390,579
$
(
10,833
)
$
621,786
$
(
79,873
)
$
1,012,365
$
(
90,706
)
At June 30, 2025, the Company held fixed maturity securities of
402
issuers that were in an unrealized loss position with a total fair value of $
890.0
million and gross unrealized losses of $
70.2
million. None of the fixed maturity securities with unrealized losses has ever missed, or been delinquent on a scheduled principal or interest payment. At June 30, 2025,
100.0
% of the Company’s fixed maturity security portfolio was rated “BBB-” or better (“investment grade”) by Standard & Poor’s or received an equivalent rating from another nationally recognized rating agency.
The Company reviews its available-for-sale fixed maturities to determine whether unrealized losses are due to credit-related factors. An allowance for credit losses is established for any credit-related impairments, limited to the amount by which fair value is below amortized cost. Changes in the allowance for credit losses are recognized in earnings and included in n
et realized and unrealized gains (losses) on investments
. Unrealized losses that are not credit-related are recognized in other comprehensive income.
The Company considers the extent to which fair value is below amortized cost in determining whether a credit-related loss exists. The Company also considers the credit quality rating of the security, with a special emphasis on securities downgraded below investment grade. A comparison is made between the present value of expected future cash flows for a security and its amortized cost. If the present value of future expected cash flows is less than amortized cost, a credit loss is presumed to exist and an allowance for credit losses is established. Management may conclude that a qualitative analysis is sufficient to support its conclusion that the present value of the expected cash flows equals or exceeds a security’s amortized cost. As a result of this review, management concluded that there were no credit-related impairments of fixed maturity securities at June 30, 2025, December 31, 2024, or June 30, 2024. During the three months ended June 30, 2024, management recognized an impairment loss of $
207,000
for one fixed maturity security due to the Company’s inability to hold the security until a recovery in its value to the amortized cost basis. For securities in an unrealized loss position at June 30, 2025, management does not intend to sell the securities, and
it is not “more likely than not” that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs.
Notes to Condensed Consolidated Financial Statements (continued)
The Company elected the fair value option to account for bank loan participations. Under the fair value option, bank loan participations are measured at fair value, and changes in unrealized gains and losses in bank loan participations are reported in the income statement as net realized and unrealized gains (losses) on investments. Applying the fair value option to the bank loan portfolio increases volatility in the Company's financial statements, but management believes it is less subjective and less burdensome to implement and maintain than ASU 2016-13, which would have otherwise been required.
At June 30, 2025, the Company's bank loan portfolio had an aggregate fair value of $
158.9
million and unpaid principal of
$
164.6
million.
Investment income on bank loan participations included in net investment income was $
3.1
million
and
$
6.3
million for the
three and six
months ended June 30, 2025, respectively (
$
4.6
million
and
$
9.1
million for the respective prior year periods)
.
Net realized and unrealized gains (losses) on bank loan participations were
$
253,000
and $(
2.1
) million
for the
three and six
months ended June 30, 2025, respectively (
$(
843,000
)
and $(
1.1
) million in the respective prior year periods)
. As of June 30, 2025, management concluded that none of the unrealized losses of bank loan participations were due to credit-related impairments. For the
three and six months ended June 30, 2024
, management concluded that
$
1.4
million and $
2.6
million
of the net realized and unrealized losses were due to credit-related impairments. Losses due to credit-related impairments are determined based upon consultations and advice from the Company's specialized investment manager and consideration of any adverse situations that could affect the borrower's ability to repay, the estimated value of underlying collateral, and other relevant factors.
Bank loan participations generally provide a higher yield than our portfolio of fixed maturities and have a credit rating that is below investment grade (i.e. below “BBB-” for Standard & Poor’s) at the date of purchase. These bank loans are primarily senior, secured floating-rate debt rated “BB”, “B”, or “CCC” by Standard & Poor’s or an equivalent rating from another nationally recognized rating agency. These bank loans include assignments of, and participations in, performing and non-performing senior corporate debt generally acquired through primary bank syndications and in secondary markets. Bank loans consist of, but are not limited to, term loans, the funded and unfunded portions of revolving credit loans, and other similar loans and investments. Management believed that it was probable at the time that these loans were acquired that the Company would be able to collect all contractually required payments receivable.
Interest income on bank loan participations is accrued on the unpaid principal balance, and discounts and premiums on bank loan participations are amortized to income using the interest method. Generally, the accrual of interest on a bank loan participation is discontinued when the contractual payment of principal or interest has become 90 days past due or management has serious doubts about further collectability of principal or interest. A bank loan participation may remain on accrual status if it is in the process of collection and is either guaranteed or well secured. Generally, bank loan participations are restored to accrual status when the obligation is brought current, has performed in accordance with the contractual terms for a reasonable period of time, and the ultimate collectability of the total contractual principal and interest is no longer in doubt. Interest received on nonaccrual loans generally is reported as investment income. There were no bank loans on nonaccrual status at June 30, 2025 or December 31, 2024.
Notes to Condensed Consolidated Financial Statements (continued)
The Company invests selectively in private debt and equity opportunities. These investments, which together comprise the Company’s other invested assets, are primarily focused in renewable energy, limited partnerships, and private debt.
Carrying Value
Investment Income
June 30,
December 31,
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
2025
2024
(in thousands)
Renewable energy LLCs
(a)
Excess and Surplus Lines
$
7,322
$
7,690
$
(
320
)
$
948
$
(
320
)
$
662
Corporate & Other
—
—
—
293
—
293
7,322
7,690
(
320
)
1,241
(
320
)
955
Renewable energy notes receivable (
b)
Excess and Surplus Lines
—
—
—
—
—
61
Corporate & Other
—
—
—
—
—
77
—
—
—
—
—
138
Limited partnerships
(c)
Excess and Surplus Lines
17,278
14,644
851
517
860
402
Corporate & Other
464
464
—
—
—
—
17,742
15,108
851
517
860
402
Private Debt
(d)
Excess and Surplus Lines
33,076
13,902
455
151
646
269
Corporate & Other
—
—
—
—
—
—
33,076
13,902
455
151
646
269
Total other invested assets
Excess and Surplus Lines
57,676
36,236
986
1,616
1,186
1,394
Corporate & Other
464
464
—
293
—
370
$
58,140
$
36,700
$
986
$
1,909
$
1,186
$
1,764
(a)
The Company's Excess and Surplus Lines segment owns equity interests ranging from
3.6
% to
5.0
% in various LLCs whose principal objective is capital appreciation and income generation from owning and operating renewable energy production facilities (wind and solar). The equity method is used to account for the Company’s LLC investments. Income for the LLCs primarily reflects adjustments to the carrying values of investments in renewable energy projects to their determined fair values. The fair value adjustments are included in revenues for the LLCs. Expenses for the LLCs are not significant and are comprised of administrative and interest expenses. In the three months ended June 30, 2024, the Company received $
1.2
million of additional proceeds from a previous sale of
two
LLCs including $
880,000
in the Excess and Surplus Lines and $
293,000
in the Corporate and Other segment. The Company received cash distributions from these investments totaling $
48,000
and $
161,000
in the six months ended June 30, 2025 and 2024, respectively.
(b)
The Company's
Excess and Surplus Lines and
Corporate and Other segments invested in
two
notes receivable for renewable energy projects. Interest on the notes was fixed at
12
%. During the
six months ended June 30, 2024
, the Company received final principal repayments of $
608,000
and $
761,000
on the notes receivable in the Company's Excess and Surplus Lines segment and Corporate and Other segment, respectively.
(c)
The Company owns investments in limited partnerships that invest in concentrated portfolios including publicly-traded small cap equities, loans of middle market private equity sponsored companies, private equity general partnership interests, commercial mortgage-backed securities, specialty private credit, and tranches of distressed home loans.
Income f
rom the partnerships is recognized under the equity method of accounting. At June 30, 2025, the Company’s Excess and Surplus Lines segment has outstanding commitments to invest another $
9.3
million in the limited partnerships.
(d)
The Company's Excess and Surplus Lines segment has invested in
seven
notes receivable for structured private specialty credit. Interest on two notes maturing in 2031 is fixed at
4.25
% and
5.25
%. Interest on two notes maturing in 2035 is fixed at
Notes to Condensed Consolidated Financial Statements (continued)
6.50
% and
8.00
%. At June 30, 2025, the Company’s Excess and Surplus Lines segment has outstanding commitments to invest another $
5.6
million in these notes.
On April 11, 2025, the Company entered into an investment agreement with Sixth Street, the parent of Enstar. Pursuant to the agreement, the Company's Excess and Surplus Lines segment has invested in collateralized investment grade notes receivable for structured private specialty credit. Interest on
three
notes maturing in 2064 is fixed at
6.79
%,
8.04
%, and
9.04
%. At June 30, 2025, the Company’s Excess and Surplus Lines segment has outstanding commitments to invest another $
64.6
million in the notes.
4.
Goodwill and Intangible Assets
On December 11, 2007, the Company completed an acquisition of James River Group by acquiring
100
% of the outstanding shares of James River Group common stock, referred to herein as the “Merger”. The transaction was accounted for under the purchase method of accounting, and goodwill and intangible assets were recognized by the Company as a result of the transaction. Goodwill resulting from the Merger was $
181.8
million at June 30, 2025 and December 31, 2024.
The gross carrying amounts and accumulated amortization for each major specifically identifiable intangible asset class were as follows:
June 30, 2025
December 31, 2024
Life
(Years)
Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
($ in thousands)
Intangible Assets
Trademarks
Indefinite
$
19,700
$
—
$
19,700
$
—
Insurance licenses and authorities
Indefinite
8,964
—
8,964
—
Identifiable intangible assets not subject to amortization
28,664
—
28,664
—
Broker relationships
24.6
11,611
8,007
11,611
7,825
Identifiable intangible assets subject to amortization
Notes to Condensed Consolidated Financial Statements (continued)
5.
Earnings Per Share
The following represents a reconciliation of the numerator and denominator of the basic and diluted earnings per common share computations contained in the condensed consolidated financial statements:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands, except share and per share amounts)
Net income from continuing operations
$
5,120
$
14,478
$
16,108
$
37,986
Less: Dividends on Series A preferred shares
(
1,969
)
(
2,625
)
(
3,938
)
(
5,250
)
Income from continuing operations available to common shareholders
$
3,151
$
11,853
$
12,170
$
32,736
Loss from discontinued operations
(
361
)
(
6,853
)
(
1,775
)
(
14,958
)
Net income available to common shareholders
$
2,790
$
5,000
$
10,395
$
17,778
Weighted average common shares outstanding:
Basic
46,032,626
37,869,322
45,918,697
37,801,516
Dilutive potential common shares
693,629
168,071
513,784
6,961,047
Diluted
46,726,255
38,037,393
46,432,481
44,762,563
Net income (loss) per common share:
Basic
Continuing operations
$
0.07
$
0.31
$
0.27
$
0.87
Discontinued operations
$
(
0.01
)
$
(
0.18
)
$
(
0.04
)
$
(
0.40
)
$
0.06
$
0.13
$
0.23
$
0.47
Diluted
Continuing operations
$
0.07
$
0.31
$
0.26
$
0.85
Discontinued operations
$
(
0.01
)
$
(
0.18
)
$
(
0.04
)
$
(
0.33
)
$
0.06
$
0.13
$
0.22
$
0.52
For the
three and six
months ended June 30, 2025, potential common shares of
13,521,634
were excluded from the calculation of diluted earnings per common share as their effects were anti-dilutive
. For the
three months ended June 30, 2024
, potential common shares of
6,848,763
were excluded from the calculation of diluted earnings per common share as their effects were anti-dilutive. For the six months ended June 30, 2024
, all potential common shares were dilutive and included in the
calculation of diluted earnings per common share
.
The Company amended the Series A Preferred Shares on November 11, 2024, which, among other things, reduced the voluntary conversion price (see Note 13). The lower conversion price results in a higher number of potential common shares under an assumed conversion when the Series A Preferred Shares are determined to be dilutive in the earnings per share calculation. In applying the if-converted method in the calculation of diluted earnings per share from continuing operations when the Series A Preferred Shares are dilutive, the dividends on the Series A Preferred Shares are added back to income from continuing operations available to common shareholders in the numerator of the calculation and the additional common shares from an assumed conversion of the Series A Preferred Shares are added in the denominator of the calculation.
Notes to Condensed Consolidated Financial Statements (continued)
6.
Reserve for Losses and Loss Adjustment Expenses
The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses, net of reinsurance, to the gross amounts reported in the condensed consolidated balance sheets. Reinsurance recoverables on unpaid losses and loss adjustment expenses are presented gross of an allowance for credit losses on reinsurance balances of $
1.5
million at June 30, 2025 and March 31, 2025, $
1.2
million at December 31, 2024, $
744,000
at June 30, 2024, and $
660,000
at March 31, 2024 and December 31, 2023.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Reserve for losses and loss adjustment expenses net of reinsurance recoverables at beginning of period
$
1,095,761
$
1,283,386
$
1,086,278
$
1,246,973
Add: Incurred losses and loss adjustment expenses net of reinsurance:
Current year
100,875
108,497
202,459
222,946
Prior years - retroactive reinsurance
9,239
(
3,684
)
7,311
(
7,686
)
Prior years - excluding retroactive reinsurance
3,027
10,658
2,896
10,260
Total incurred losses and loss and adjustment expenses
113,141
115,471
212,666
225,520
Deduct: Loss and loss adjustment expense payments net of reinsurance:
Current year
4,005
6,189
5,736
8,283
Prior years
106,477
94,690
196,716
170,234
Total loss and loss adjustment expense payments
110,482
100,879
202,452
178,517
Deduct: Change in deferred reinsurance gain - retroactive reinsurance
9,239
(
3,684
)
7,311
(
7,686
)
Reserve for losses and loss adjustment expenses net of reinsurance recoverables at end of period
1,089,181
1,301,662
1,089,181
1,301,662
Add: Reinsurance recoverables on unpaid losses and loss adjustment expenses at end of period
1,987,317
1,418,536
1,987,317
1,418,536
Reserve for losses and loss adjustment expenses gross of reinsurance recoverables on unpaid losses and loss adjustment expenses at end of period
$
3,076,498
$
2,720,198
$
3,076,498
$
2,720,198
The Company experienced $
3.0
million of net adverse reserve development in the three months ended June 30, 2025 on the reserve for losses and loss adjustment expenses held at December 31, 2024 (excluding adverse prior year development subject to retroactive reinsurance accounting - see
Loss Portfolio Transfers and Adverse Development Covers
below). This reserve development included $
2.3
million of net adverse development in the Excess and Surplus Lines segment and $
700,000
of net adverse development in the Specialty Admitted Insurance segment.
The Company experienced $
10.7
million of net adverse reserve development in the three months ended June 30, 2024 on the reserve for losses and loss adjustment expenses held at December 31, 2023 (excluding adverse prior year development subject to retroactive reinsurance accounting - see
Loss Portfolio Transfers and Adverse Development Covers
below). This reserve development included $
10.7
million of net adverse development in the Excess and Surplus Lines segment.
The Company experienced $
2.9
million of net adverse reserve development in the six months ended June 30, 2025 on the reserve for losses and loss adjustment expenses held at December 31, 2024 (excluding adverse prior year development subject to retroactive reinsurance accounting - see
Loss Portfolio Transfers and Adverse Development Covers
below). This reserve development included $
2.3
million of net adverse development in the Excess and Surplus Lines segment and $
579,000
of net adverse development in the Specialty Admitted Insurance segment.
The Company experienced $
10.3
million of net adverse reserve development in the six months ended June 30, 2024 on the reserve for losses and loss adjustment expenses held at December 31, 2023 (excluding adverse prior year development subject to retroactive reinsurance accounting - see
Loss Portfolio Transfers and Adverse Development Covers
below). This reserve development included $
10.7
million of net adverse development in the Excess and Surplus Lines segment and $
442,000
of net favorable development in the Specialty Admitted Insurance segment.
Notes to Condensed Consolidated Financial Statements (continued)
Loss Portfolio Transfers and Adverse Development Covers
Loss portfolio transfers and adverse development covers are forms of retroactive reinsurance utilized by the Company to transfer losses and loss adjustment expenses and associated risk of adverse development on covered subject business, as defined in the respective agreements, to an assuming reinsurer in exchange for a reinsurance premium. This reinsurance can bring economic finality (up to the limit of such agreements, if applicable) on the subject risks when they no longer meet the Company's risk appetite or are no longer aligned with the Company's risk management guidelines.
Commercial Auto Loss Portfolio Transfer
On September 27, 2021, James River Insurance and James River Casualty Company (together, “James River”) entered into a loss portfolio transfer transaction (the “Commercial Auto LPT”) with Aleka Insurance, Inc. (“Aleka”), a captive insurance company affiliate of Rasier LLC, to reinsure substantially all of the Excess and Surplus Lines segment's legacy portfolio of commercial auto policies previously issued to Rasier LLC and its affiliates (collectively, “Rasier”) for which James River is not otherwise indemnified by Rasier. The reinsurance coverage is structured to be fully collateralized, is not subject to an aggregate limit, and is subject to certain exclusions. The cumulative amounts ceded under the loss portfolio transfer were $
458.0
million and $
459.3
million as of June 30, 2025 and December 31, 2024, respectively.
Combined Loss Portfolio Transfer and Adverse Development Cover
On July 2, 2024, James River entered into a Combined Loss Portfolio Transfer and Adverse Development Cover Reinsurance Contract (the “E&S ADC”) with State National Insurance Company, Inc. (“State National”). The transaction closed upon signing.
The E&S ADC was effective January 1, 2024 (the “Effective Date”) and applies to James River’s Excess & Surplus Lines segment casualty portfolio losses attaching to premium earned during 2010-2023 (both years inclusive), excluding, among others, losses related to commercial auto policies issued to a former large insured or its affiliates (the “Subject Business”). Pursuant to the E&S ADC, (a) State National reinsures
85
% of losses paid on and after the Effective Date in respect of the Subject Business in excess of $
716.6
million up to an aggregate limit of $
467.1
million (with State National’s share of the aggregate limit being $
397.0
million) in exchange for a reinsurance premium paid by James River equal to $
313.2
million, and (b) James River continues to manage claims and to manage and collect the benefit of other existing third-party reinsurance on the Subject Business, which third-party reinsurance inures to the benefit of the E&S ADC. The Company has $
28.8
million of aggregate limit remaining on the E&S ADC at June 30, 2025.
Adverse Development Cover
On November 11, 2024, Enstar Group Limited (“Enstar”), through its subsidiary Cavello Bay Reinsurance Limited (“Cavello Bay”), entered into an adverse development cover agreement with James River (“E&S Top Up ADC”), pursuant to which, in exchange for a premium of $
52.8
million (less an amount equal to the federal excise tax payable on the premium), Cavello Bay reinsures, effective January 1, 2024,
100
% of the losses associated with James River’s Excess & Surplus Lines segment casualty portfolio losses attaching to premium earned during 2010-2023 (both years inclusive). The E&S Top Up ADC excludes losses related to commercial auto policies issued to a former large insured or its affiliates and is subject to a retention by James River of $
1,183.7
million (the limit of the E&S ADC executed on July 2, 2024) and up to an aggregate limit of $
75.0
million. The E&S Top Up ADC closed on December 23, 2024. The Company recognized a $
52.8
million reduction in pre-tax income in connection with the adverse development cover upon closing. The Company has $
75.0
million of aggregate limit remaining on the E&S Top Up ADC at June 30, 2025.
Retroactive Reinsurance Accounting
The Company periodically reevaluates the remaining reserves subject to the Commercial Auto LPT, the E&S ADC, and the E&S Top Up ADC, and when recognized adverse prior year development on the subject business causes the cumulative amounts ceded under the agreements to exceed the consideration paid, the agreements move into a gain position subject to retroactive reinsurance accounting under GAAP. Gains are deferred under retroactive reinsurance accounting and recognized in earnings in proportion to actual paid recoveries under the agreements using the recovery method. While the deferral of gains can introduce volatility in the Company's operating results in the short-term, over the life of the contract, we would expect no economic impact to the Company as long as the counterparty performs under the contract. The impact of retroactive reinsurance accounting is not indicative of the Company's current and ongoing operations.
Notes to Condensed Consolidated Financial Statements (continued)
The following tables summarize the retroactive reinsurance accounting for the Commercial Auto LPT and the E&S ADC for the three and six months ended June 30, 2025 and 2024, respectively.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Commercial Auto LPT
Deferred retroactive reinsurance gain at beginning of period
$
7,294
$
16,731
$
9,222
$
20,733
(Favorable) adverse prior year development ceded on subject business
(
1,414
)
1,420
(
1,270
)
1,897
Retroactive reinsurance benefits under the recovery method
71
(
5,104
)
(
2,001
)
(
9,583
)
Deferred retroactive reinsurance gain at end of period
$
5,951
$
13,047
$
5,951
$
13,047
E&S ADC
Deferred retroactive reinsurance gain at beginning of period
$
48,748
$
—
$
48,748
$
—
Adverse prior year development ceded on subject business
10,582
—
10,582
—
Retroactive reinsurance benefits under the recovery method
—
—
—
—
Deferred retroactive reinsurance gain at end of period
$
59,330
$
—
$
59,330
$
—
Total
Deferred retroactive reinsurance gain at beginning of period
$
56,042
$
16,731
$
57,970
$
20,733
Adverse prior year development ceded on subject business
9,168
1,420
9,312
1,897
Retroactive reinsurance benefits under the recovery method
71
(
5,104
)
(
2,001
)
(
9,583
)
Deferred retroactive reinsurance gain at end of period
$
65,281
$
13,047
$
65,281
$
13,047
7.
Other Comprehensive Income (Loss)
The following table summarizes the components of other comprehensive income (loss):
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Unrealized gains (losses) arising during the period, before U.S. income taxes
$
6,237
$
(
3,784
)
$
24,391
$
(
13,934
)
U.S. income taxes
(
1,310
)
795
(
5,122
)
2,926
Unrealized gains (losses) arising during the period, net of U.S. income taxes
4,927
(
2,989
)
19,269
(
11,008
)
Less reclassification adjustment:
Net realized investment gains (losses)
—
(
798
)
25
(
1,109
)
U.S. income taxes
—
168
(
5
)
233
Reclassification adjustment for investment losses realized in net income
—
(
630
)
20
(
876
)
Other comprehensive income (loss)
$
4,927
$
(
2,359
)
$
19,249
$
(
10,132
)
In addition to the net realized investment gains (losses) on available-for-sale fixed maturities disclosed above, the Company also recognized net realized and unrealized investment gains (losses) on its investments in bank loan participations and equity securities in the respective periods. Refer to Note 3 for disclosure of these amounts.
Notes to Condensed Consolidated Financial Statements (continued)
8.
Contingent Liabilities
Legal Proceedings
The Company is involved in various legal proceedings, including commercial matters and litigation regarding insurance claims which arise in the ordinary course of business. In addition, the Company is involved from time to time in legal actions which seek extra-contractual damages, punitive damages or penalties, including claims alleging bad faith in the handling of insurance claims. The Company believes that the outcome of such matters, individually and in the aggregate, is not reasonably likely to have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows.
On March 11, 2024, the Company filed a complaint in the Supreme Court of the State of New York, New York County, Commercial Division against Fleming relating to the Stock Purchase Agreement, pursuant to which Fleming agreed to purchase all of the outstanding common shares of JRG Re (the “Transaction”). The complaint alleges that Fleming breached the Stock Purchase Agreement by its refusal to close the Transaction on March 1, 2024 as required under the terms of the Stock Purchase Agreement, and seeks specific performance of Fleming’s obligation to complete the Transaction and an award of damages. The Company subsequently filed a motion for preliminary injunction to require Fleming to fulfill its contractual obligation to close the Transaction, and on April 6, 2024 the Court granted the Company’s motion and ordered Fleming to complete the Transaction on or prior to April 16, 2024. On April 8, 2024, Fleming filed a notice of appeal of the preliminary injunction, which Fleming withdrew on October 9, 2024. The Transaction closed on April 16, 2024. On April 19, 2024, Fleming filed a motion to dismiss the complaint. On May 9, 2024, the Company filed an amended complaint seeking, among other things, specific performance and damages suffered as a result of Fleming's breach of the Stock Purchase Agreement. On June 6, 2024, Fleming filed a motion to dismiss the amended complaint, on July 3, 2024 the Company filed an opposition to the motion to dismiss, on July 24, 2024 Fleming filed its reply to the opposition, and on October 29, 2024 the court heard oral argument on the motion to dismiss.
On July 15, 2024, Fleming filed a lawsuit in the U.S. District Court, Southern District of New York against JRG Holdings and certain of its officers, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, common law fraud, and breaches of contract, and seeking unspecified monetary damages, including compensatory, consequential and punitive damages, all associated with Fleming's purchase of JRG Re pursuant to the Stock Purchase Agreement. On July 31, 2024, Fleming filed an amended complaint, on September 13, 2024, the Company filed a motion to dismiss the amended complaint, and on October 18, 2024 Fleming filed a second amended complaint. On November 15, 2024, the Company filed a motion to dismiss the second amended complaint, on December 23, 2024 Fleming filed an opposition to the motion to dismiss, on January 17, 2025 the Company filed its reply to Fleming's opposition, on July 2, 2025 the court heard oral argument on the motion to dismiss, and on July 17, 2025 the court granted the Company's motion to dismiss.
The deadline for Fleming to file a notice of appeal is August 18, 2025.
Amounts Recoverable from Reinsurers
The Company’s insurance segments remain liable to policyholders if its reinsurers are unable to meet their contractual obligations under applicable reinsurance agreements. We establish an allowance for credit losses for our current estimate of uncollectible reinsurance recoverables. At June 30, 2025, the allowance for credit losses on reinsurance recoverables was $
1.5
million. To minimize exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk. The Company generally seeks to purchase reinsurance from reinsurers with A.M. Best financial strength ratings of “A-” (Excellent) or better. The Company’s reinsurance contracts generally require reinsurers that are not authorized as reinsurers under U.S. state insurance regulations or that experience rating downgrades from rating agencies below specified levels to fund their share of the Company’s ceded outstanding losses and loss adjustment expense reserves, typically through the use of irrevocable and unconditional letters of credit. In fronting arrangements, which the Company conducts through its Specialty Admitted Insurance segment, we are subject to credit risk with regard to insurance companies who act as reinsurers for us in such arrangements. We require collateral, in the form of a trust arrangement or letter of credit, to secure the obligations of the insurance entity for whom we are fronting.
Amounts Recoverable from an Indemnifying Party and Reinsurer on Legacy Commercial Auto Book
James River previously issued a set of commercial auto insurance contracts (the “Rasier Commercial Auto Policies”) to Rasier under which James River pays losses and loss adjustment expenses on the contracts. James River has indemnity agreements with Rasier (non-insurance entities) (collectively, the “Indemnity Agreements”) and is contractually entitled to reimbursement for the portion of the losses and loss adjustment expenses paid on behalf of Rasier under the Rasier Commercial Auto Policies and other expenses incurred by James River. In addition, on September 27, 2021, James River entered into the Commercial Auto LPT with Aleka to reinsure substantially all of the Rasier Commercial Auto Policies for which James River is not otherwise indemnified by Rasier under the Indemnity Agreements.
Notes to Condensed Consolidated Financial Statements (continued)
Each of Rasier and Aleka are required to post collateral equal to
102
% of James River's estimate of the respective party's obligations in trusts pursuant to the terms of the Indemnity Agreements and the Commercial Auto LPT, respectively. At June 30, 2025, the total balance of collateral securing Rasier's obligations under the Indemnity Agreements was $
55.3
million and Aleka's obligations under the Commercial Auto LPT was $
26.5
million. At June 30, 2025, the total reinsurance recoverables under the Commercial Auto LPT was $
24.1
million.
In connection with the execution of the Commercial Auto LPT, James River and Aleka entered into an administrative services agreement (the “Administrative Services Agreement”) with a third party claims administrator (the “Administrator”) pursuant to which the Administrator handles the claims on the Rasier Commercial Auto Policies for the remaining life of those claims. The claims paid by the Administrator are reimbursable by James River, and pursuant to the Administrative Services Agreement, James River established a loss fund trust account for the benefit of the Administrator (the “Loss Fund Trust”) to collateralize its claims payment reimbursement obligations. James River funds the Loss Fund Trust using funds withdrawn from the Indemnity Trust, funds withdrawn from the LPT Trust, and its own funds, in each case in an amount equal to the pro rata portion of the required Loss Fund Trust balance attributable to the Indemnity Agreements, the Commercial Auto LPT and James River’s existing third party reinsurance agreements, respectively. At June 30, 2025, the balance in the Loss Fund Trust was $
29.3
million, including $
17.4
million representing collateral supporting Rasier’s obligations under the Indemnity Agreements and $
7.7
million representing collateral supporting Aleka’s obligations under the Commercial Auto LPT. Funds posted to the Loss Fund Trust are classified as restricted cash equivalents on the Company's balance sheet.
While the Commercial Auto LPT brings economic finality to substantially all of the Rasier Commercial Auto Policies, the Company has credit exposure to Rasier and Aleka under the Indemnity Agreements and the Commercial Auto LPT if the estimated losses and expenses of the Rasier Commercial Auto Policies grow at a faster pace than the growth in the collateral balances. In addition, the Company has credit exposure if its estimates of future losses and loss adjustment expenses and other amounts recoverable under the Indemnity Agreements and the Commercial Auto LPT, which are the basis for establishing the collateral balances, are lower than actual amounts paid or payable. The amount of the Company's credit exposure in any of these instances could be material. To mitigate these risks, the Company closely and frequently monitors its exposure compared to the collateral held, and requests additional collateral in accordance with the terms of the Commercial Auto LPT and Indemnity Agreements when its analysis indicates that it has uncollateralized exposure.
9.
Segment Information
The Company’s continuing operations are comprised of
three
reportable segments, two of which are separately managed business units and the third (“Corporate and Other”) includes the Company’s remaining operations. The Excess and Surplus Lines segment primarily offers commercial excess and surplus lines liability and excess property insurance products. The Specialty Admitted Insurance segment offers specialty admitted fronting and program business and, prior to the sale of the Company's renewal rights in 2023, workers’ compensation insurance coverage. The Corporate and Other segment consists of certain management and treasury activities of James River Group, James River UK, and JRG Holdings as well as interest expense associated with senior debt and Junior Subordinated Debt, and investment income. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. Prior to entering into a definitive agreement to sell JRG Re on November 8, 2023, JRG Re was considered a reportable segment (the “Casualty Reinsurance” segment). After entering into the agreement to sell JRG Re, the Company no longer considers Casualty Reinsurance to be a reportable segment, but instead it is reported as discontinued operations. The segment information below excludes discontinued operations for all periods presented.
Segment profit (loss) is measured by underwriting profit (loss), which is generally defined as net earned premiums and gross fee income (in specific instances when the Company is not retaining insurance risk) in “other income” in the Condensed Consolidated Statements of Income and Comprehensive Income less loss and loss adjustment expenses on business not subject to retroactive reinsurance accounting (see
Retroactive Reinsurance Accounting
in
Note 6 - Reserve for Losses and Loss Adjustment Expenses
) and other operating expenses. Other operating expenses include the underwriting, acquisition, and insurance expenses of the operating segments and, for consolidated underwriting profit, the expenses of the Corporate and Other segment. Other operating expenses for the Corporate and Other segment include personnel costs associated with the Bermuda and U.S. holding companies, professional fees, long-term incentive compensation (including share-based compensation) for the full Company, public company expenses and various other corporate expenses. Net commissions in the table below are net of amounts deferred as deferred policy acquisition costs. Employee compensation includes both cash and share-based compensation, as well as employer expenses related to payroll taxes and benefits, and is net of amounts allocated to losses and loss adjustment expenses and amounts deferred. All other operating expenses include, amongst other expenses, costs for insurance, outside professional fees including legal, audit, and consulting, office rent, bad debt expense, and taxes, licenses and fees on business written. Segment results are reported prior to the effects of intercompany pooling agreements and intercompany reinsurance agreements. All gross written premiums and net earned premiums for all periods presented were
Notes to Condensed Consolidated Financial Statements (continued)
generated from policies issued to U.S. based insureds. Segment revenues for each reportable segment include net earned premiums, net investment income, and realized and unrealized (losses) gains on investments.
The Company's Chief Executive Officer (“CEO”) has final authority over segment resource allocation decisions and performance assessment, and consequently, is identified as the Chief Operating Decision Maker (“CODM”). The CEO considers segment underwriting profit (loss) in the annual budget and forecasting process, and in monthly financial reviews of actual segment results compared to budget and prior year periods in order to assess segment performance and make strategic operating decisions regarding the business written by the segments, the allocation of capital and personnel to the segments, and compensation for segment employees. The segment information presented below aligns with the information that is presented regularly to the CEO.
The following table summarizes the Company’s segment results:
Excess and
Surplus
Lines
Specialty
Admitted
Insurance
Corporate
and
Other
Total
(in thousands)
As of and for the Three Months Ended June 30, 2025
Gross written premiums
$
300,444
$
77,559
$
—
$
378,003
Net earned premiums
141,370
11,239
—
152,609
Fee income
—
828
—
828
Losses and loss adjustment expenses
103,099
10,042
—
113,141
Less: losses and loss adjustment expense - retroactive reinsurance
9,239
—
—
9,239
Losses and loss adjustment expenses excluding retroactive reinsurance
Notes to Condensed Consolidated Financial Statements (continued)
Excess and
Surplus
Lines
Specialty
Admitted
Insurance
Corporate
and
Other
Total
(in thousands)
As of and for the Six Months Ended June 30, 2024
Gross written premiums
$
506,527
$
236,530
$
—
$
743,057
Net earned premiums
286,070
48,814
—
334,884
Fee income
—
2,587
—
2,587
Losses and loss adjustment expenses
187,452
38,068
—
225,520
Less: losses and loss adjustment expense - retroactive reinsurance
(
7,686
)
—
—
(
7,686
)
Losses and loss adjustment expenses excluding retroactive reinsurance
195,138
38,068
—
233,206
Other operating expenses:
Net commissions
27,171
(
6,670
)
—
20,501
Employee compensation
30,915
6,652
13,436
51,003
All other operating expenses
7,928
9,149
6,325
23,402
66,014
9,131
19,761
94,906
Underwriting profit (loss)
24,918
4,202
(
19,761
)
9,359
Segment revenues
328,493
59,591
1,332
389,416
Net investment income
38,681
8,083
799
47,563
Interest expense
—
—
12,829
12,829
Segment goodwill
181,831
—
—
181,831
Segment assets
3,211,050
1,385,738
141,418
4,738,206
The following table reconciles the underwriting profit (loss) of the operating segments by individual segment to consolidated income from continuing operations before income taxes:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Underwriting profit (loss) of the operating segments:
Excess and Surplus Lines
$
11,707
$
6,427
$
23,365
$
24,918
Specialty Admitted Insurance
(
1,421
)
3,416
(
1,727
)
4,202
Total underwriting profit of operating segments
10,286
9,843
21,638
29,120
Other operating expenses of the Corporate and Other segment
(
8,222
)
(
8,624
)
(
18,853
)
(
19,761
)
Underwriting profit
2,064
1,219
2,785
9,359
Losses and loss adjustment expenses – retroactive reinsurance
(
9,239
)
3,684
(
7,311
)
7,686
Net investment income
20,516
24,931
40,524
47,563
Net realized and unrealized (losses) gains on investments
(
352
)
(
2,305
)
(
1,723
)
2,278
Other income and expenses
234
(
905
)
589
(
726
)
Interest expense
(
5,805
)
(
6,344
)
(
11,346
)
(
12,829
)
Amortization of intangible assets
(
91
)
(
91
)
(
182
)
(
182
)
Income from continuing operations before income taxes
Notes to Condensed Consolidated Financial Statements (continued)
10.
Other Operating Expenses and Other Expenses
Other operating expenses consist of the following:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Amortization of policy acquisition costs
$
17,396
$
13,765
$
34,936
$
31,805
Other underwriting expenses of the operating segments
21,853
21,707
44,242
43,340
Other operating expenses of the Corporate and Other segment
8,222
8,624
18,853
19,761
Total
$
47,471
$
44,096
$
98,031
$
94,906
Other expenses of $
1.0
million and $
1.6
million for the three and six
months ended June 30, 2025
, respectively ($
2.1
million and $
2.8
million in the respective prior year periods), primarily consist of certain nonoperating expenses including legal and other professional fees and other expenses related to various strategic initiatives.
11.
Senior Debt
On June 12, 2025, the Company entered into a Credit Agreement (the “Credit Agreement”). The Credit Agreement replaced the Company’s previous Third Amended and Restated Credit Agreement dated as of July 7, 2023, as amended (the “Previous Credit Agreement”), that provided for a $
212.5
million unsecured revolving credit facility and a $
45.0
million secured revolving credit facility.
The Credit Agreement provides for a $
212.5
million unsecured revolving credit facility available for general corporate purposes and matures on June 12, 2028. Following the sale of JRG Re, the Company no longer has a need for the secured revolving credit facility provided by the Previous Credit Agreement. The interest rates applicable to the loans under the Credit Agreement are generally based on the Secured Overnight Financing Rate (“SOFR”) plus a specified margin based on the Company’s Leverage Ratio (as defined in the Credit Agreement). In addition, the Company will pay an unused facility fee on each lender’s commitment.
At
June 30, 2025
, the Company had a drawn balance of $
210.8
million outstanding on the unsecured revolver of the Credit Agreement, including $
25.0
million previously borrowed on January 27, 2025 under the Previous Credit Agreement which was contributed to our regulated insurance entities.
The Credit Agreement provides for an accordion feature that permits the Company to request that one or more lenders (without the consent of the other lenders) or new financial institutions (with the consent of the Administrative Agent) provide it with increases in the credit facility of up to an aggregate of $
30.0
million, subject to satisfaction of certain conditions.
The Credit Agreement contains customary representations and warranties, affirmative and negative covenants and events of default. The Credit Agreement also includes financial covenants, including a maximum leverage ratio and minimum consolidated net worth, risk-based capital ratio and financial strength rating requirements
with which the Company was in compliance at
June 30, 2025.
In connection with the Credit Agreement, James River UK and James River Group each entered into a Continuing Guaranty of Payment dated June 12, 2025 (each, a “Payment Guaranty”). Pursuant to its respective Payment Guaranty, each of James River UK and James River Group guarantees the payment and performance of the Company’s obligations under the Credit Agreement and other loan documents.
12.
Fair Value Measurements
Three levels of inputs are used to measure fair value of financial instruments: (1) Level 1: quoted price (unadjusted) in active markets for identical assets, (2) Level 2: inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument, and (3) Level 3: inputs to the valuation methodology are unobservable for the asset or liability.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.
The fair values of fixed maturity securities, equity securities, and bank loan participations have been determined using fair value prices provided by the Company’s investment accounting services provider or investment managers, who utilize
Notes to Condensed Consolidated Financial Statements (continued)
internationally recognized independent pricing services. The prices provided by the independent pricing services are generally based on observable market data in active markets (
e.g.
broker quotes and prices observed for comparable securities). Values for U.S. Treasury and publicly-traded equity securities are generally based on Level 1 inputs which use the market approach valuation technique. The values for all other fixed maturity securities (including state and municipal securities and obligations of U.S. government corporations and agencies) and bank loan participations generally incorporate significant Level 2 inputs, and in some cases, Level 3 inputs, using the market approach and income approach valuation techniques. There have been no changes in the Company’s use of valuation techniques since December 31, 2023.
The Company reviews fair value prices provided by its outside investment accounting service provider or investment managers for reasonableness by comparing the fair values provided by the managers to those provided by its investment custodian. The Company also reviews and monitors changes in unrealized gains and losses. The Company has not historically adjusted security prices. The Company obtains an understanding of the methods, models and inputs used by the investment managers and independent pricing services, and controls are in place to validate that prices provided represent fair values. The Company’s control process includes, but is not limited to, initial and ongoing evaluation of the methodologies used, a review of specific securities and an assessment for proper classification within the fair value hierarchy, and obtaining and reviewing internal control reports for our investment manager that obtains fair values from independent pricing services.
Assets measured at fair value on a recurring basis as of June 30, 2025 are summarized below:
Fair Value Measurements Using
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
(in thousands)
Fixed maturity securities, available-for-sale:
State and municipal
$
—
$
199,490
$
—
$
199,490
Residential mortgage-backed
—
397,110
—
397,110
Corporate
—
528,508
—
528,508
Commercial mortgage and asset-backed
—
156,817
—
156,817
U.S. Treasury securities and obligations guaranteed by the U.S. government
18,292
—
—
18,292
Total fixed maturity securities, available-for-sale
Notes to Condensed Consolidated Financial Statements (continued)
Assets measured at fair value on a recurring basis as of December 31, 2024 are summarized below:
Fair Value Measurements Using
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
(in thousands)
Fixed maturity securities, available-for-sale:
State and municipal
$
—
$
196,564
$
—
$
196,564
Residential mortgage-backed
—
326,227
—
326,227
Corporate
—
475,485
—
475,485
Commercial mortgage and asset-backed
—
170,458
—
170,458
U.S. Treasury securities and obligations guaranteed by the U.S. government
20,999
—
—
20,999
Total fixed maturity securities, available-for-sale
$
20,999
$
1,168,734
$
—
$
1,189,733
Equity securities:
Preferred stock
—
71,245
—
71,245
Common stock
12,693
2,536
5
15,234
Total equity securities
$
12,693
$
73,781
$
5
$
86,479
Bank loan participations
$
—
$
142,410
$
—
$
142,410
Short-term investments
$
—
$
97,074
$
—
$
97,074
A reconciliation of the beginning and ending balances of available-for-sale fixed maturity securities, equity securities, and bank loan participations measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is shown below:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Beginning balance
$
2
$
17
$
5
$
11
Transfers out of Level 3
—
—
—
—
Transfers in to Level 3
—
—
—
—
Purchases
—
—
—
—
Sales
—
—
—
—
Maturities, calls and paydowns
—
—
—
—
Amortization of discount
—
—
—
—
Total gains or losses (realized/unrealized):
Included in earnings
(
1
)
(
12
)
(
4
)
(
6
)
Included in other comprehensive income
—
—
—
—
Ending balance
$
1
$
5
$
1
$
5
The Company held
one
equity security at December 31, 2024 and June 30, 2025 for which the fair value was determined using significant unobservable inputs (Level 3). The fair value of $
1,000
at June 30, 2025 for the equity security was obtained from our asset manager and was derived from an internal model.
The Company held
one
equity security at December 31, 2023 and June 30, 2024 for which the fair value was determined using significant unobservable inputs (Level 3). The fair value of $
5,000
at June 30, 2024 for the equity security was obtained from our asset manager and was derived from an internal model.
Notes to Condensed Consolidated Financial Statements (continued)
Transfers out of Level 3 occur when the Company is able to obtain reliable prices from pricing vendors for securities for which the Company was previously unable to obtain reliable prices. Transfers in to Level 3 occur when the Company is unable to obtain reliable prices for securities from pricing vendors and instead must use broker price quotes to value the securities.
There were no transfers between Level 1 and Level 2 during the six months ended June 30, 2025 or 2024. The Company recognizes transfers between levels at the beginning of the reporting period.
In the determination of the fair value for bank loan participations and certain high yield bonds, the Company’s investment manager endeavors to obtain data from multiple external pricing sources. External pricing sources may include brokers, dealers and price data vendors that provide a composite price based on prices from multiple dealers. Such external pricing sources typically provide valuations for normal institutional size trading units of such securities using methods based on market transactions for comparable securities, and various relationships between securities, as generally recognized by institutional dealers. For investments in which the investment manager determines that only one external pricing source is appropriate or if only one external price is available, the relevant investment is generally recorded at fair value based on such price.
Investments for which external sources are not available or are determined by the investment manager not to be representative of fair value are recorded at fair value as determined by the Company, with input from its investment managers and valuation specialists as considered necessary. In determining the fair value of such investments, the Company considers one or more of the following factors: type of security held, convertibility or exchangeability of the security, redeemability of the security (including the timing of redemptions), application of industry accepted valuation models, recent trading activity, liquidity, estimates of liquidation value, purchase cost, and prices received for securities with similar terms of the same issuer or similar issuers. At June 30, 2025 and December 31, 2024, there were no investments for which external sources were unavailable to determine fair value.
The carrying values and fair values of financial instruments are summarized below:
June 30, 2025
December 31, 2024
Carrying
Value
Fair Value
Carrying
Value
Fair Value
(in thousands)
Assets
Fixed maturity securities, available-for-sale
$
1,300,217
$
1,300,217
$
1,189,733
$
1,189,733
Equity securities
88,042
88,042
86,479
86,479
Bank loan participations
158,871
158,871
142,410
142,410
Cash and cash equivalents
220,041
220,041
362,345
362,345
Restricted cash equivalents
29,321
29,321
28,705
28,705
Short-term investments
111,216
111,216
97,074
97,074
Other invested assets – notes receivable
33,076
33,899
13,902
12,877
Liabilities
Senior debt
225,800
234,431
200,800
201,787
Junior subordinated debt
104,055
121,250
104,055
121,766
The fair values of fixed maturity securities, equity securities, and bank loan participations have been determined using quoted market prices for securities traded in the public market or prices using bid or closing prices for securities not traded in the public marketplace. The fair values of cash and cash equivalents and short-term investments approximate their carrying values due to their short-term maturity.
The fair values of other invested assets-notes receivable, senior debt, and junior subordinated debt at June 30, 2025 and December 31, 2024 were determined by calculating the present value of expected future cash flows under the terms of the note agreements or debt agreements, as applicable, discounted at an estimated market rate of interest at June 30, 2025 and December 31, 2024, respectively. The Company also utilized an internally developed valuation model based on the spread of a comparable market index to determine the fair value of certain other invested assets-notes receivable at June 30, 2025 and December 31, 2024.
The fair values of senior debt, junior subordinated debt, and investments in notes receivable, classified in other invested assets, at June 30, 2025 and December 31, 2024 were determined using inputs to the valuation methodology that are unobservable (Level 3).
Notes to Condensed Consolidated Financial Statements (continued)
13.
Series A Preferred Shares
The Company has
112,500
7
% Series A Perpetual Cumulative Convertible Preferred Shares, par value $
0.00125
per share (the “Series A Preferred Shares”) outstanding as of June 30, 2025 and December 31, 2024. The Series A Preferred Shares were issued on March 1, 2022 and are held by GPC Partners Investments (Thames) LP (“GPC Partners”), an affiliate of Gallatin Point Capital LLC.
The Series A Preferred Shares rank senior to our common shares with respect to dividend rights and rights on the distribution of assets on any liquidation, dissolution or winding up of the affairs of the Company, upon which the holders of Series A Preferred Shares would receive the greater of the $
1,000
liquidation preference per share (the “Liquidation Preference”) plus accrued and unpaid dividends, or the amount they would have received if they had converted all of their Series A Preferred Shares to common shares immediately before such liquidation, dissolution or winding up.
Holders of the Series A Preferred Shares are entitled to a dividend at the rate of
7
% of the Liquidation Preference per annum, paid in cash, in-kind in common shares or in Series A Preferred Shares, at the Company’s election. On October 1, 2029, and each
five-year
anniversary thereafter, the dividend rate will reset to a rate equal to the
five-year
U.S. treasury rate plus
5.2
%, subject to a cap of
8.0
%. Dividends accrue and are payable quarterly. Cash dividends of $
3.9
million and $
5.3
million were paid on the Series A Preferred Shares in the six months ended June 30, 2025 and 2024, respectively.
The Series A Preferred Shares are convertible at the option of the holders thereof at any time into common shares at a conversion price of $
8.32
, making the Series A Preferred Shares convertible into
13,521,634
common shares. The conversion price is subject to customary anti-dilution adjustments, including cash dividends on the common shares above specified levels.
The Certificate of Designations setting forth the terms of the Series A Preferred Shares (the “Certificate of Designations”) limits the Company's ability to pay dividends to its common shareholders. If the Company pays cash dividends of more than $
0.05
per common share per quarter, without the consent of at least the majority of the Series A Preferred Shares then outstanding, the Company will be required to reduce the conversion price of the Series A Preferred Shares. Additionally, the payment of cash dividends in excess of $
0.10
per common share per quarter is not permitted if the dividends on the Series A Preferred Shares for that quarter are not paid in cash, unless the Company’s insurance subsidiaries satisfy certain capital requirements. Share dividends payable on the common shares to the Company's shareholders also trigger a reduction of the conversion price applicable to the Series A Preferred Shares. None of the triggers that would result in additional adjustments to the conversion price have been met at June 30, 2025.
If at any time the volume-weighted average price (“VWAP”) per common share is greater than
200
% of the then applicable conversation price for at least
twenty
(20) consecutive trading days, the Company will be able to elect to convert (a “Mandatory Conversion”) all of the outstanding Series A Preferred Shares into common shares. In the case of a Mandatory Conversion, each Series A Preferred Share then outstanding will be converted into (i) the number of common shares equal to the quotient of (A) the sum of the Liquidation Preference and the accrued and unpaid dividends with respect to such Series A Preferred Share to be converted divided by (B) the conversion price of such share in effect as of the date of the Mandatory Conversion plus (ii) cash in lieu of fractional shares.
Upon any Mandatory Conversion on or before March 1, 2027, all dividends that would have accrued from the date of the Mandatory Conversion to the later of March 1, 2027 or the last day of the eighth quarter following the date of the Mandatory Conversion, the last eight quarters of which will be discounted to present value using a discount rate of
3.5
% per annum, and will be immediately payable in common shares, valued at the average of the daily VWAP of the Company’s common shares during the
five
(5) trading days immediately preceding the conversion.
The holders of the Series A Preferred Shares may require the Company to repurchase their shares upon the occurrence of certain change of control events. Upon the occurrence of a Fundamental Change (as defined in the Certificate of Designations), each holder of outstanding Series A Preferred Shares will be permitted to, at its election, (i) effective as of immediately prior to the Fundamental Change, convert all or a portion of its Series A Preferred Shares into common shares, or (ii) require the Company to repurchase any or all of such holder’s Series A Preferred Shares at a purchase price per Series A Preferred Share equal to the Liquidation Preference of such Series A Preferred Share plus accrued and unpaid dividends plus, if the Fundamental Change repurchase occurs prior to March 1, 2027, all dividends that would have accrued up to such date, but that have not been paid. The repurchase price will be payable in cash.
Because the Company may be required to repurchase all or a portion of the Series A Preferred Shares at the option of the holder upon the occurrence of certain change of control events, the Series A Preferred Shares are classified as mezzanine equity in the Company's condensed consolidated balance sheets and recognized at their determined fair value of $
133.1
million. The Series A Preferred Shares were valued using a lattice method commonly applied to value preferred shares. The Series A Preferred Shares are classified as Level 3 in the valuation hierarchy due to the presence of significant unobservable inputs.
Notes to Condensed Consolidated Financial Statements (continued)
The Certificate of Designations limits transfers of the Series A Preferred Shares without the Company’s consent if, after the transfer, the transferee would hold
9.9
% or more of the voting equity of the Company or, in the event of an A.M. Best downgrade of James River Insurance Company below A- (Excellent),
19.9
% of the voting equity.
Under the terms of the Investment Agreement, GPC Partners has the right to designate one member of the Board (the “Series A Designee”). GPC Partners designated Matthew Botein as the Series A Designee, and Mr. Botein was approved by the Board as a Class I director with a term that expired at the 2024 annual general meeting of the Company’s shareholders. Mr. Botein was re-elected as a director at the 2024 annual general meeting for a term ending at the 2025 annual general meeting.
14.
Capital Stock and Equity Awards
Common Shares
Total common shares outstanding increased from
45,644,318
at December 31, 2024 to
45,895,335
at June 30, 2025, reflecting
251,017
common shares issued in the six months ended June 30, 2025 related to vesting of RSUs.
Dividends
The Company declared the following dividends on common shares during the first six months of 2025 and 2024:
Date of Declaration
Dividend per Common Share
Payable to Shareholders of Record on
Payment Date
Total Amount
2025
February 20, 2025
$
0.01
March 10, 2025
March 31, 2025
$
477,412
April 24, 2025
$
0.01
June 9, 2025
June 30, 2025
476,186
$
0.02
$
953,598
2024
February 15, 2024
$
0.05
March 11, 2024
March 29, 2024
$
1,940,410
April 25, 2024
$
0.05
June 10, 2024
June 28,2024
1,938,439
$
0.10
$
3,878,849
Included in the total dividends for the six months ended June 30, 2025 and 2024 are $
36,000
and $
96,000
, respectively, of dividend equivalents on unvested RSUs. The balance of dividends payable on unvested RSUs was $
137,000
at June 30, 2025 and $
252,000
at December 31, 2024.
Equity Incentive Plans
The Company’s shareholders have approved various equity incentive plans, including the 2014 Long Term Incentive Plan (“2014 LTIP”) and the 2014 Non-Employee Director Incentive Plan (“2014 Director Plan”) (collectively, the “Plans”). All awards issued under the Plans are issued at the discretion of the Board of Directors.
Employees are eligible to receive non-qualified stock options, incentive stock options, share appreciation rights, performance shares, restricted shares, RSUs, and other awards under the 2014 LTIP. At June 30, 2025, the maximum number of shares available for issuance under the 2014 LTIP was
5,507,650
and
599,695
shares were available for grant.
On July 26, 2022, the Board of Directors of the Company approved a new long-term incentive plan (the “LTI Plan”) under the 2014 LTIP. The LTI Plan is designed to align compensation of designated senior officers of the Company with Company performance and shareholder interests over the long-term. Awards under the LTI Plan are made in the form of performance restricted share units (a “PRSU”) and service based restricted share units (RSUs).
Each PRSU represents a contingent right to receive
one
Company common share based upon the level of achievement of certain performance metrics during the performance period, with payout for achievement of threshold, target and maximum performance levels to be set at
50
%,
100
% and
200
% of the target number of PRSUs, respectively. The PRSUs awarded in the first quarter of 2023 have a performance period of January 1, 2023 through December 31, 2025. The PRSUs awarded in the first quarter of 2024 have a performance period of January 1, 2024 through December 31, 2026. The PRSUs awarded in the first quarter of 2025 have a performance period of January 1, 2025 through December 31, 2027.
Notes to Condensed Consolidated Financial Statements (continued)
Non-employee directors of the Company are eligible to receive non-qualified stock options, share appreciation rights, performance shares, restricted shares, RSUs, and other awards under the 2014 Director Plan. At June 30, 2025, the maximum number of shares available for issuance under the 2014 Director Plan was
250,000
and
50,410
shares were available for grant.
Generally, awards issued under the 2014 LTIP and 2014 Director Plan vest immediately in the event that an award recipient is terminated without Cause (as defined in the applicable plans), and in the case of the 2014 LTIP for Good Reason (as defined in the applicable plans), at any time following a Change in Control (as defined in the applicable plans).
RSUs
The following table summarizes RSU activity:
Six Months Ended June 30,
2025
2024
Shares
Weighted-
Average
Grant Date
Fair Value
Shares
Weighted-
Average
Grant Date
Fair Value
Unvested, beginning of period
885,173
$
15.30
751,254
$
23.48
Granted
1,321,733
$
3.68
537,060
$
9.76
Vested
(
362,216
)
$
18.00
(
268,993
)
$
25.11
Forfeited
(
121,369
)
$
6.50
(
76,305
)
$
15.56
Unvested, end of period
1,723,321
$
6.44
943,016
$
15.84
Outstanding RSUs granted to employees generally vest ratably over a
three year
vesting period in the case of time-vest RSUs and cliff vest at the end of a
three-year
performance period in the case of PRSUs. RSUs granted to non-employee directors generally have a
one year
vesting period. The holders of RSUs are entitled to dividend equivalents. The dividend equivalents are settled in cash at the same time that the underlying RSUs vest and are subject to the same risk of forfeiture as the underlying shares. The fair value of the RSUs granted is generally based on the market price of the underlying shares at the date of grant. The RSUs granted in 2025 and 2024 include
620,108
and
231,492
PRSU awards, respectively. Initial PRSU awards are granted at the
100
% target performance level. The Company projects the level of achievement for each award during the performance period and periodically adjusts the number of outstanding awards to reflect the number of awards expected to vest.
Options
At December 31, 2023, the Company had
74,390
options outstanding with an average weighted exercise price of $
42.17
. The options lapsed in the six months ended June 30, 2024, after which, there have been
no
options outstanding.
Compensation Expense
Share based compensation expense is recognized on a straight-line basis over the vesting period. The amount of expense and related tax benefit is summarized below:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Share based compensation expense
$
834
$
1,553
$
3,494
$
4,228
U.S. tax benefit on share based compensation expense
134
293
651
790
At June 30, 2025, the Company had $
6.9
million of unrecognized share based compensation expense expected to be charged to earnings over a weighted-average period of
2.0
years.
15.
Subsequent Events
On July 24, 2025, the Board of Directors declared a cash dividend of $
0.01
per common share. The dividend is payable on
September 30, 2025
to shareholders of record on
September 15, 2025
.
On July 24, 2025, the Board of Directors declared a dividend of up to $
2.0
million on the Series A Preferred Shares. The dividend will be payable in cash on
September 30, 2025
to shareholders of record on
September 15, 2025
.
Notes to Condensed Consolidated Financial Statements (continued)
On July 24, 2025, the Board of Directors approved awards under the 2014 LTIP and the 2014 Director Plan to the Company’s employees and directors with fair values of $
250,000
and $
31,000
, respectively, and grant dates of August 6, 2025 and July 24, 2025, respectively.
On
July 17, 2025, the U.S. District Court, Southern District of New York granted the Company’s motion to dismiss the lawsuit filed on July 15, 2024 by Fleming against JRG Holdings and certain of its officers, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, common law fraud, and breaches of contract associated with Fleming’s purchase of JRG Re pursuant to the Stock Purchase Agreement. The deadline for Fleming to file a notice of appeal is August 18, 2025.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. Factors that could cause such differences are discussed in the sections entitled “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q, and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025, or for any other future period. The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024.
The accompanying condensed consolidated financial statements and related notes have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and include the accounts of James River Group Holdings, Ltd. and its subsidiaries. Unless the context indicates or suggests otherwise, references to “the Company”, “we”, “us” and “our” refer to James River Group Holdings, Ltd. and its subsidiaries.
Our Business
James River Group Holdings, Ltd. (“JRG Holdings”) is a Bermuda-based holding company. We own and operate a group of five insurance companies with the objective of generating compelling returns on tangible equity while limiting underwriting and investment volatility. We seek to accomplish this by earning profits from insurance underwriting and generating meaningful investment returns, while managing our capital to meet our risk management, regulatory and rating agency requirements.
We report our continuing operations in three reportable segments:
•
The Excess and Surplus Lines segment offers commercial excess and surplus lines liability and property insurance in every U.S. state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands through James River Insurance Company and its wholly-owned subsidiary, James River Casualty Company;
•
The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where we retain a minority share of the risk and earn fee income by allowing other carriers and producers to use our licensure, ratings, expertise and infrastructure. Through Falls Lake National and its subsidiaries, this segment has admitted licenses and the authority to write excess and surplus lines insurance in 50 states and the District of Columbia and distributes through a variety of sources, including program administrators and managing general agents;
•
The Corporate and Other segment consists of the management, technology, and treasury activities of our holding companies, interest expense associated with our debt, and expenses of our holding companies, including public company expenses and long-term incentive compensation (including share-based compensation) for the group.
Our discontinued operations include JRG Reinsurance Company Ltd. (“JRG Re”), which comprised the remaining operations of the former Casualty Reinsurance segment, and which, prior to the suspension of its underwriting activities in 2023, provided proportional and working layer casualty reinsurance to third parties. On November 8, 2023, the Company entered into a definitive agreement to sell JRG Re. The sale of JRG Re, which closed on April 16, 2024, resulted in the Company’s disposition of its casualty reinsurance business and related assets. The Company has no continued involvement with JRG Re following the sale.
All of the Company’s U.S.-domiciled insurance subsidiaries are party to an intercompany reinsurance “pooling” agreement that distributes the net underwriting results among the group companies based on their approximate pro-rata level of statutory capital and surplus to the total Company statutory capital and surplus. We report all segment information in this ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’ prior to the effects of intercompany reinsurance, consistent with the manner in which we evaluate the operating performance of our reportable segments.
The A.M. Best Company financial strength rating for our U.S. insurance subsidiaries is “A-” (Excellent).
Key Metrics
We discuss certain key metrics, described below, which we believe provide useful information about our business and the operational factors underlying our financial performance.
Underwriting profit
is a non-GAAP measure commonly used in the property and casualty insurance industry to evaluate underwriting performance. We believe that the disclosure of underwriting profit by individual segment and of the Company as a whole is useful to investors, analysts, rating agencies and other users of our financial information in evaluating our performance
because our objective is to consistently earn underwriting profits. We evaluate the performance of our segments and allocate resources based primarily on the potential for underwriting profit. We define underwriting profit as net earned premiums and gross fee income (in specific instances when the Company is not retaining insurance risk) less losses and loss adjustment expenses on business from continuing operations not subject to retroactive reinsurance accounting and other operating expenses. Other operating expenses include the underwriting, acquisition, and insurance expenses of the operating segments and, for consolidated underwriting profit, the expenses of the Corporate and Other segment. Our definition of underwriting profit may not be comparable to that of other companies. See “Reconciliation of Non-GAAP Measures” for a reconciliation of underwriting profit to income from continuing operations before taxes and for additional information.
Loss ratio
, expressed as a percentage, is the ratio of losses and loss adjustment expenses on business from continuing operations not subject to retroactive reinsurance accounting to net earned premiums. Our definition of loss ratio may not be comparable to that of other companies. See “Underwriting Performance Ratios” for a reconciliation of underwriting ratios.
Accident year loss ratio
, expressed as a percentage, is the ratio of losses and loss adjustment expenses for the current accident year (excluding development on prior accident year reserves) to net earned premiums for the current year (excluding ceded earned premium associated with adverse development covers covering prior accident years and net earned premium adjustments on certain reinsurance treaties with reinstatement premiums associated with prior years).
Expense ratio
, expressed as a percentage, is the ratio of other operating expenses net of gross fee income included in other income to net earned premiums.
Combined ratio
is a measure of underwriting performance calculated as the sum of the loss ratio and the expense ratio. A combined ratio of less than 100% indicates an underwriting profit, while a combined ratio greater than 100% reflects an underwriting loss. Our definition of combined ratio may not be comparable to that of other companies. See “Underwriting Performance Ratios” for a reconciliation of underwriting ratios.
Adjusted net operating income
is an internal performance measure used in the management of our operations. We believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted net operating income is defined as income available to common shareholders excluding a) income (loss) from discontinued operations b) the impact of retroactive reinsurance accounting, c) net realized and unrealized gains (losses) on investments, d) certain non-operating expenses such as professional service fees related to certain lawsuits, various strategic initiatives, and the filing of registration statements for the offering of securities, e) severance costs associated with terminated employees, and f) deemed dividends recorded with the amendment of the Series A Preferred Shares. Adjusted net operating income is a non-GAAP measure and should not be viewed as a substitute for net income calculated in accordance with GAAP. Our definition of adjusted net operating income may not be comparable to that of other companies. See “Reconciliation of Non-GAAP Measures” for a reconciliation of income available to common shareholders to adjusted net operating income.
Tangible equity
is defined as shareholders' equity plus mezzanine Series A Preferred Shares (as defined below) and the unrecognized deferred retroactive reinsurance gain less goodwill and intangible assets, net of amortization. Tangible equity is a non-GAAP measure and should not be viewed as a substitute for shareholders’ equity calculated in accordance with GAAP. Our definition of tangible equity may not be comparable to that of other companies. See “Reconciliation of Non-GAAP Measures” for a reconciliation of shareholders' equity to tangible equity.
Tangible equity per share
represents tangible equity divided by the sum of total common shares outstanding plus the common shares resulting from an assumed conversion of the outstanding Series A Preferred Shares into common shares (at the conversion price effective as of the last day of the applicable period).
Tangible common equity
is defined as shareholders' equity plus the unrecognized deferred retroactive reinsurance gain less goodwill and intangible assets, net of amortization. We believe tangible common equity is a good measure to evaluate the strength of our balance sheet and to compare returns relative to this measure. Key financial measures that we use to assess our longer term financial performance include the percentage growth in our tangible common equity per share and our return on tangible common equity. Tangible common equity is a non-GAAP measure and should not be viewed as a substitute for shareholders’ equity calculated in accordance with GAAP. Our definition of tangible common equity may not be comparable to that of other companies. See “Reconciliation of Non-GAAP Measures” for a reconciliation of shareholders' equity to tangible common equity.
Adjusted net operating return on tangible common equity
is defined as annualized adjusted net operating income expressed as a percentage of the average quarterly tangible common equity balances in the respective period.
Tangible common equity per share
represents tangible common equity divided by the total common shares outstanding.
Net retention
is defined as the ratio of net written premiums to gross written premiums.
Gross investment yield
is annualized investment income before any deductions for fees and expenses, expressed as a percentage of the average beginning and ending carrying values of those investments during the period.
Unless specified otherwise, all references to our defined metrics above in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations”
are for our business from continuing operations that is not subject to retroactive reinsurance accounting. Management believes that the lack of economic impact of retroactive reinsurance accounting makes the presentation of our key metrics on business not subject to retroactive reinsurance accounting helpful to the users of our financial information. See “Underwriting Performance Ratios” and “Reconciliation of Non-GAAP Measures.”
Critical Accounting Policies and Estimates
In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ significantly from those estimates.
The most critical accounting policies involve significant estimates and include those used in determining the reserve for losses and loss adjustment expenses and investment valuation and impairment. For a detailed discussion of each of these policies, refer to our Annual Report on Form 10-K for the year ended December 31, 2024. There have been no significant changes to any of these policies during the current year.
Recent Strategic Actions
In the fourth quarter of 2024, the Board of Directors concluded the strategic review process announced in November of 2023. While the strategic review process has been completed, in the ordinary course of business the Company and Board of Directors expect to consider opportunities consistent with its fiduciary duty.
Combined Loss Portfolio Transfer and Adverse Development Cover
On July 2, 2024, James River Insurance and James River Casualty (together, “James River”), entered into a Combined Loss Portfolio Transfer and Adverse Development Cover Reinsurance Contract (the “E&S ADC”) with State National Insurance Company, Inc. (“State National”). The transaction closed upon signing.
The E&S ADC was effective January 1, 2024 (the “Effective Date”) and applies to James River’s Excess & Surplus Lines segment casualty portfolio losses attaching to premium earned during 2010-2023 (both years inclusive), excluding, among others, losses related to commercial auto policies issued to a former large insured or its affiliates (the “Subject Business”). Pursuant to the E&S ADC, (a) State National reinsures 85% of losses paid on and after the Effective Date in respect of the Subject Business in excess of $716.6 million up to an aggregate limit of $467.1 million (with State National’s share of the aggregate limit being $397.0 million) in exchange for a reinsurance premium paid by James River equal to $313.2 million, and (b) James River continues to manage claims and to manage and collect the benefit of other existing third-party reinsurance on the Subject Business, which third-party reinsurance inures to the benefit of the E&S ADC. The Company has $28.8 million of aggregate limit remaining on the E&S ADC at June 30, 2025.
Enstar Strategic Relationship
The Company commenced a multi-pronged strategic relationship with Enstar Group Limited (“Enstar”). As part of this, on November 11, 2024, Enstar, through its subsidiary Cavello Bay Reinsurance Limited (“Cavello Bay”), entered into (i) a subscription agreement to purchase $12.5 million of the Company’s common shares at a share price of $6.40, which shares are in addition to 637,640 shares Enstar previously purchased in the open market, and (ii) an adverse development cover agreement with James River (the “E&S Top Up ADC”). Pursuant to the E&S Top Up ADC, in exchange for a premium of $52.8 million (less an amount equal to the federal excise tax payable on the premium), Cavello Bay reinsures, effective January 1, 2024, 100% of the losses associated with James River’s Excess & Surplus Lines segment casualty portfolio losses attaching to premium earned during 2010-2023 (both years inclusive). This agreement excludes losses related to commercial auto policies issued to a former large insured or its affiliates. It is subject to a retention by James River of $1,183.7 million (the limit of the E&S ADC) and up to an aggregate limit of $75.0 million. Enstar’s purchase of common shares and the E&S Top Up ADC closed on December 23, 2024. The Company recognized a $52.8 million reduction in pre-tax income in connection with the E&S Top Up ADC upon closing. The Company has $75.0 million of aggregate limit remaining on the E&S Top Up ADC at June 30, 2025.
Series A Preferred Share Amendment
On November 11, 2024, the Company amended the Certificate of Designations setting forth the terms of the Series A Preferred Shares held by GPC Partners to, among other things, (i) convert $37.5 million of the outstanding Series A Preferred Shares to common stock at a per share price of $6.40 (the “Minimum Price”), (ii) increase the voluntary conversion price from 127.5% to 130% of the Minimum Price, (iii) increase the mandatory conversion price from 130% to 200% of the voluntary
conversion price, (iv) delay the first date on which the dividend rate re-sets from March 1, 2027 to October 1, 2029, (v) cap the dividend rate at 8%, (vi) eliminate the adverse development anti-dilution adjustment provision, and (vii) limit transfers of the Series A Preferred Shares without the Company’s consent if, after the transfer, the transferee would hold 9.9% or more of the voting equity of the Company or, in the event of an A.M. Best downgrade of James River Insurance below A- (Excellent), 19.9% of the voting equity.
Losses and loss adjustment expenses excluding retroactive reinsurance
(103,902)
(119,155)
(12.8)
%
(205,355)
(233,206)
(11.9)
%
Other operating expenses
(46,643)
(42,819)
8.9
%
(96,371)
(92,319)
4.4
%
Underwriting profit
(1), (2)
2,064
1,219
69.3
%
2,785
9,359
(70.2)
%
Losses and loss adjustment expenses - retroactive reinsurance
(9,239)
3,684
—
(7,311)
7,686
—
Net investment income
20,516
24,931
(17.7)
%
40,524
47,563
(14.8)
%
Net realized and unrealized (losses) gains on investments
(352)
(2,305)
(84.7)
%
(1,723)
2,278
—
Other income and expense
234
(905)
—
589
(726)
—
Interest expense
(5,805)
(6,344)
(8.5)
%
(11,346)
(12,829)
(11.6)
%
Amortization of intangible assets
(91)
(91)
—
(182)
(182)
—
Income from continuing operations before taxes
7,327
20,189
(63.7)
%
23,336
53,149
(56.1)
%
Income tax expense on continuing operations
2,207
5,711
(61.4)
%
7,228
15,163
(52.3)
%
Net income from continuing operations
5,120
14,478
(64.6)
%
16,108
37,986
(57.6)
%
Net loss from discontinued operations
(361)
(6,853)
(94.7)
%
(1,775)
(14,958)
(88.1)
%
Net income
4,759
7,625
(37.6)
%
14,333
23,028
(37.8)
%
Dividends on Series A Preferred Shares
(1,969)
(2,625)
(25.0)
%
(3,938)
(5,250)
(25.0)
%
Net income available to common shareholders
$
2,790
$
5,000
(44.2)
%
$
10,395
$
17,778
(41.5)
%
Adjusted net operating income
(1)
$
11,693
$
12,664
(7.7)
%
$
20,795
$
27,496
(24.4)
%
Ratios:
Loss ratio
68.1
%
73.0
%
67.4
%
69.6
%
Expense ratio
30.5
%
26.3
%
31.7
%
27.6
%
Combined ratio
98.6
%
99.3
%
99.1
%
97.2
%
Accident year loss ratio
64.9
%
66.0
%
65.2
%
66.3
%
(1)
Underwriting profit and adjusted net operating income are non-GAAP measures. See “Reconciliation of Non-GAAP Measures.”
(2)
Included in underwriting results for the three and six months ended June 30, 2025 and 2024 is gross fee income of $3.9 million
and
$8.3 million, respectively ($5.6 million and $10.9 million in the respective prior year periods).
Three Months Ended June 30, 2025 and 2024
The Company produced net income from continuing operations of $5.1 million for the three months ended June 30, 2025 compared to $14.5 million for the three months ended June 30, 2024. Adjusted net operating income was $11.7 million and $12.7 million in the respective periods.
Underwriting profits were $2.1 million and $1.2 million (combined ratios of 98.6% and 99.3%) for the three months ended June 30, 2025 and 2024, respectively, reflecting higher underwriting profit in our Excess and Surplus Lines segment which was partially offset by an underwriting loss in our Specialty Admitted Insurance segment. Underwriting results for the three months
ended June 30, 2025 and 2024 include $2.7 million and $1.2 million of premium adjustments associated with prior years including reinstatement premium in the Excess and Surplus Lines segment. The premium adjustments reduced net written and net earned premiums, and underwriting profit in the respective quarters, and resulted in increases to our combined ratio of 1.7 and 0.7 percentage points, respectively.
The loss ratio for the three months ended June 30, 2025 improved compared to the prior year quarter largely driven by net reserve development on prior accident years (excluding adverse prior year development from continuing operations that is subject to retroactive reinsurance accounting - see discussion below) which was $3.0 million or 2.0 points adverse in the three months ended June 30, 2025 compared to $10.7 million or 6.5 points adverse in the three months ended June 30, 2024. Premium adjustments associated with prior years including reinstatement premium in the Excess and Surplus Lines segment increased the respective loss ratios by 1.2 and 0.5 points. The loss ratio for the current year quarter also benefited from a lower current accident year loss ratio and segment mix with the Excess and Surplus Lines segment representing 92.6% of consolidated net earned premiums in the three months ended June 30, 2025 compared to 86.1% in the three months ended June 30, 2024.
Our expense ratio increased from 26.3% in the prior year quarter to 30.5% in the current year quarter reflecting higher expense ratios for both operating segments, partially offset by lower expenses in the Corporate and Other segment. Refer to the Segment Results section below for further discussion of the segment expense ratios. Premium adjustments associated with prior years including reinstatement premium in the Excess and Surplus Lines segment increased the respective consolidated expense ratios by 0.5 and 0.3 points in the respective three month periods.
Investment income declined by $4.4 million or 17.7% in the three months ended June 30, 2025 compared to the same period in the prior year driven by lower invested assets following the funding of strategic initiatives during the second half of 2024 including the reinsurance premium paid to enter the E&S ADC and the E&S Top Up ADC, as well as lower yields. Net realized and unrealized losses on investments were lower in the current year quarter largely due to unfavorable mark-to-market adjustments in the prior year quarter on equity securities of $1.1 million and bank loan participations of $753,000 (see
Investing Results
below).
The Company entered into a definitive agreement on November 8, 2023 to sell JRG Re. The sale closed on April 16, 2024 and discontinued operations in the prior year period includes the operating results of JRG Re which were a loss of $5.7 million for the period April 1, 2024 to April 16, 2024. The loss on disposal, also included in discontinued operations above, was $361,000 and $1.2 million in the three months ended June 30, 2025 and 2024, respectively.
Adjusted net operating results decreased by $971,000 or 7.7% from the prior year quarter mostly due to the lower investment income. Growth in tangible common equity of 5.3% in the current quarter was largely driven by net income and unrealized gains on fixed maturities in other comprehensive income due to a decline in interest rates. Our 14.0% adjusted net operating return on tangible common equity for the three months ended June 30, 2025 compares to a 14.9% return for the three months ended June 30, 2024.
Six Months Ended June 30, 2025 and 2024
The Company produced net income from continuing operations of $16.1 million for the six months ended June 30, 2025 compared to $38.0 million for the six months ended June 30, 2024. Adjusted net operating income was $20.8 million and $27.5 million in the respective periods.
Underwriting profits were $2.8 million and $9.4 million (combined ratios of 99.1% and 97.2%) for the six months ended June 30, 2025 and 2024, respectively. Underwriting results for the respective six month periods include $5.8 million and $1.2 million of premium adjustments associated with prior years including reinstatement premium in the Excess and Surplus Lines segment. The premium adjustments reduced net written and net earned premiums, and underwriting profit and increased our combined ratio by 1.9 and 0.3 percentage points in the respective periods.
Our loss ratio of 67.4% for the six months ended June 30, 2025 improved compared to the prior year loss ratio of 69.6% primarily reflecting net reserve development on prior accident years (excluding adverse prior year development from continuing operations that is subject to retroactive reinsurance accounting - see discussion below) which was $2.9 million or 1.0 points adverse in the six months ended June 30, 2025 compared to $10.3 million or 3.1 points adverse in the six months ended June 30, 2024. Premium adjustments associated with prior years including reinstatement premium in the Excess and Surplus Lines segment increased the respective loss ratios by 1.2 and 0.2 points. The current year loss ratio also benefited from a lower current accident year loss ratio and segment mix with the Excess and Surplus Lines segment representing 91.4% of consolidated net earned premiums in the six months ended June 30, 2025 compared to 85.4% in the six months ended June 30, 2024.
Our expense ratio increased from 27.6% in the prior year to 31.7% in the current year reflecting higher expense ratios for both operating segments, partially offset by lower expenses in the Corporate and Other segment. Refer to the Segment Results section below for further discussion of the segment expense ratios. Premium adjustments associated with prior years including
reinstatement premium in the Excess and Surplus Lines segment increased the respective consolidated expense ratios by 0.7 and 0.1 points.
Investment income declined by $7.0 million or 14.8% in the six months ended June 30, 2025 compared to the same period in the prior year driven by lower invested assets following the funding of strategic initiatives during the second half of 2024 including the reinsurance premium paid to enter the E&S ADC and the E&S Top Up ADC, as well as lower yields. Net realized and unrealized losses on investments of $1.7 million for the six months ended June 30, 2025 include $2.1 million of net realized and unrealized losses on bank loan participations, partially offset by $313,000 of net realized and unrealized gains on equity securities. Net realized and unrealized gains of $2.3 million for the six months ended June 30, 2024 were largely due to favorable mark-to-market adjustments on equity securities of $3.1 million (see
Investing Results
below).
Discontinued operations in the prior year period includes the operating results of JRG Re which were a loss of $13.6 million for the six months ended June 30, 2024. The prior year loss from discontinued operations primarily reflects net adverse development of $7.1 million on treaties not subject to the Casualty Re loss portfolio transfer. The loss on disposal, also included in discontinued operations above, was $1.8 million and $1.4 million in the six months ended June 30, 2025 and 2024, respectively.
Adjusted net operating results declined from the prior year by $6.7 million or 24.4% due to the lower underwriting results and lower investment income. Growth in tangible common equity of 12.8% for the six months ended June 30, 2025 was largely driven by net income and unrealized gains on fixed maturities in other comprehensive income due to a decline in interest rates. Our 12.8% adjusted net operating return on tangible common equity for the six months ended June 30, 2025 compares to a 16.1% return for the six months ended June 30, 2024.
Loss Portfolio Transfers and Adverse Development Covers
Loss portfolio transfers and adverse development covers are forms of retroactive reinsurance utilized by the Company to transfer losses and loss adjustment expenses and associated risk of adverse development on covered subject business, as defined in the respective agreements, to an assuming reinsurer in exchange for a reinsurance premium. This reinsurance can bring economic finality (up to the limit of such agreements, if applicable) on the subject risks when they no longer meet the Company's risk appetite or are no longer aligned with the Company's risk management strategy. In addition to the E&S ADC and E&S Top Up ADC described in “Recent Strategic Actions”, the Company also participates in a Commercial Auto loss portfolio transfer.
Commercial Auto Loss Portfolio Transfer
On September 27, 2021, James River Insurance and James River Casualty Company (together, “James River”) entered into a loss portfolio transfer transaction (the “Commercial Auto LPT”) with Aleka Insurance, Inc. (“Aleka”), a captive insurance company affiliate of Rasier LLC, to reinsure substantially all of the Excess and Surplus Lines segment's legacy portfolio of commercial auto policies previously issued to Rasier LLC and its affiliates (collectively, “Rasier”) for which James River is not otherwise indemnified by Rasier. The reinsurance coverage is structured to be fully collateralized, is not subject to an aggregate limit, and is subject to certain exclusions. The cumulative amounts ceded under the loss portfolio transfer were $458.0 million and $459.3 million as of June 30, 2025 and December 31, 2024, respectively.
Retroactive Reinsurance Accounting
The Company periodically reevaluates the remaining reserves subject to the Commercial Auto LPT, the E&S ADC, and the E&S Top Up ADC, and when recognized adverse prior year development on the subject business causes the cumulative amounts ceded under the agreements to exceed the consideration paid, the agreements move into a gain position subject to retroactive reinsurance accounting under GAAP. Gains are deferred under retroactive reinsurance accounting and recognized in earnings in proportion to actual paid recoveries under the agreements using the recovery method. While the deferral of gains can introduce volatility in our results in the short-term, over the life of the contract, we would expect no economic impact to the Company as long as the counterparty performs under the contract and losses are within the limit (if any). The impact of retroactive reinsurance accounting is not indicative of our current and ongoing operations.
The following tables summarize the retroactive reinsurance accounting for the Commercial Auto LPT and the E&S ADC for the three and six months ended June 30, 2025 and 2024, respectively.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Commercial Auto LPT
Deferred retroactive reinsurance gain at beginning of period
$
7,294
$
16,731
$
9,222
$
20,733
(Favorable) adverse prior year development ceded on subject business
(1,414)
1,420
(1,270)
1,897
Retroactive reinsurance benefits under the recovery method
71
(5,104)
(2,001)
(9,583)
Deferred retroactive reinsurance gain at end of period
$
5,951
$
13,047
$
5,951
$
13,047
E&S ADC
Deferred retroactive reinsurance gain at beginning of period
$
48,748
$
—
$
48,748
$
—
Adverse prior year development ceded on subject business
10,582
—
10,582
—
Retroactive reinsurance benefits under the recovery method
—
—
—
—
Deferred retroactive reinsurance gain at end of period
$
59,330
$
—
$
59,330
$
—
Total
Deferred retroactive reinsurance gain at beginning of period
$
56,042
$
16,731
$
57,970
$
20,733
Adverse prior year development ceded on subject business
9,168
1,420
9,312
1,897
Retroactive reinsurance benefits under the recovery method
71
(5,104)
(2,001)
(9,583)
Deferred retroactive reinsurance gain at end of period
$
65,281
$
13,047
$
65,281
$
13,047
Premiums
Insurance premiums are earned ratably over the terms of our insurance policies, generally twelve months. The following table summarizes the change in premium volume by component and business segment:
Three Months Ended
June 30,
%
Six Months Ended
June 30,
%
2025
2024
Change
2025
2024
Change
($ in thousands)
Gross written premiums:
Excess and Surplus Lines
$
300,444
$
292,836
2.6
%
$
513,687
$
506,527
1.4
%
Specialty Admitted Insurance
77,559
119,411
(35.0)
%
158,677
236,530
(32.9)
%
$
378,003
$
412,247
(8.3)
%
$
672,364
$
743,057
(9.5)
%
Net written premiums:
Excess and Surplus Lines
$
166,645
$
161,601
3.1
%
$
281,724
$
279,026
1.0
%
Specialty Admitted Insurance
9,345
19,752
(52.7)
%
22,222
40,499
(45.1)
%
$
175,990
$
181,353
(3.0)
%
$
303,946
$
319,525
(4.9)
%
Net earned premiums:
Excess and Surplus Lines
$
141,370
$
140,447
0.7
%
$
278,398
$
286,070
(2.7)
%
Specialty Admitted Insurance
11,239
22,746
(50.6)
%
26,113
48,814
(46.5)
%
$
152,609
$
163,193
(6.5)
%
$
304,511
$
334,884
(9.1)
%
Gross written premiums for the Excess and Surplus Lines segment (which represents 76.4% of our consolidated gross written premiums from continuing operations in the six months ended June 30, 2025) grew by 2.6% and 1.4% over the three and six month periods in the prior year driven by expansion in our largest underwriting divisions. Given changes in our underwriting appetite, we are being selective in certain lines of business. Submissions for Core E&S lines (excluding
commercial auto) for the six months ended June 30, 2025 was 5.7% higher than the same period in the prior year. The number of bound policies in the six months ended June 30, 2025 declined 2.5% from the prior year period, and average premium size decreased 16.0% due to our focus on writing smaller accounts and the mix of business. Renewal rates for the Excess and Surplus Lines segment were up 13.9% and 11.7% compared to the three and six months ended June 30, 2024, respectively. The increases were widespread across most underwriting divisions. Excess Casualty, our largest division, saw increases of 24.2% and 20.2% compared to the three and six month prior year periods. The change in gross written premiums was notable in several divisions as shown below:
Three Months Ended
June 30,
%
Six Months Ended
June 30,
%
2025
2024
Change
2025
2024
Change
($ in thousands)
Excess Casualty
$
101,034
$
96,462
4.7
%
$
171,796
$
166,292
3.3
%
General Casualty
73,772
69,506
6.1
%
117,430
113,258
3.7
%
Manufacturers & Contractors
47,274
46,445
1.8
%
87,900
84,349
4.2
%
Excess Property
14,895
18,426
(19.2)
%
26,486
31,995
(17.2)
%
Energy
17,275
15,487
11.5
%
24,699
24,300
1.6
%
Allied Health
11,056
8,829
25.2
%
18,305
15,560
17.6
%
Environmental
4,604
5,832
(21.1)
%
7,666
11,076
(30.8)
%
All other Core E&S divisions
24,580
24,517
0.3
%
46,742
47,564
(1.7)
%
Total Core E&S divisions
294,490
285,504
3.1
%
501,024
494,394
1.3
%
Commercial Auto
$
5,954
$
7,332
(18.8)
%
12,663
12,133
4.4
%
Excess and Surplus Lines gross written premium
$
300,444
$
292,836
2.6
%
$
513,687
$
506,527
1.4
%
Gross written premiums for the Specialty Admitted Insurance segment (which represents 23.6% of our consolidated gross written premiums for the six months ended June 30, 2025) declined from the three and six month periods in the prior year driven by several non-renewals in our fronting business, reflective of the Company's strategy to remain opportunistic in the current market environment and manage this segment to retain minimal risk. Individual risk workers' compensation premium continues to run off following the sale of the renewal rights to that business in 2023.
Net Retention
Our net premium retention is summarized by segment as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
Excess and Surplus Lines
55.5
%
55.2
%
54.8
%
55.1
%
Specialty Admitted Insurance
12.0
%
16.5
%
14.0
%
17.1
%
Total
46.6
%
44.0
%
45.2
%
43.0
%
Net premium retention for the Excess and Surplus Lines segment in the three and six months ended June 30, 2025 was impacted by $2.7 million and $5.8 million ($1.2 million in each of the respective three and six month prior year periods) of premium adjustments associated with prior years including reinstatement premium which reduced net written premiums and the net retention ratio.
The net premium retention for the fronting business in the Specialty Admitted Insurance segment declined in the three and six months ended June 30, 2025 as compared to the respective prior year periods due to the mix of business, including the impact of certain non-renewals in our fronting business, and changes in reinsurance as coverages renew.
The following table presents our combined ratios by segment:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
Excess and Surplus Lines
91.7
%
95.4
%
91.6
%
91.3
%
Specialty Admitted Insurance
112.6
%
85.0
%
106.6
%
91.4
%
Total
98.6
%
99.3
%
99.1
%
97.2
%
Excess and Surplus Lines Segment
Results for the Excess and Surplus Lines segment are as follows:
Three Months Ended
June 30,
%
Six Months Ended
June 30,
%
2025
2024
Change
2025
2024
Change
($ in thousands)
Gross written premiums
$
300,444
$
292,836
2.6
%
$
513,687
$
506,527
1.4
%
Net written premiums
$
166,645
$
161,601
3.1
%
$
281,724
$
279,026
1.0
%
Net earned premiums
$
141,370
$
140,447
0.7
%
$
278,398
$
286,070
(2.7)
%
Losses and loss adjustment expenses excluding retroactive reinsurance
(93,860)
(101,533)
(7.6)
%
(182,664)
(195,138)
(6.4)
%
Underwriting expenses
(35,803)
(32,487)
10.2
%
(72,369)
(66,014)
9.6
%
Underwriting profit
(1)
$
11,707
$
6,427
82.2
%
$
23,365
$
24,918
(6.2)
%
Ratios:
Loss ratio
66.4
%
72.3
%
65.6
%
68.2
%
Expense ratio
25.3
%
23.1
%
26.0
%
23.1
%
Combined ratio
91.7
%
95.4
%
91.6
%
91.3
%
Accident year loss ratio
63.5
%
64.2
%
63.5
%
64.2
%
(1)
Underwriting Profit is a non-GAAP Measure. See “Reconciliation of Non-GAAP Measures.”
The Excess and Surplus Lines segment produced underwriting profits of $11.7 million and $6.4 million (combined ratios of 91.7% and 95.4%) in the three months ended June 30, 2025 and 2024, respectively. The underwriting results for the respective three month periods were impacted by $2.7 million and $1.2 million of premium adjustments associated with prior years including reinstatement premium which reduced net written and net earned premiums, and underwriting profit. The premium adjustments increased the segment combined ratios by 1.7 and 0.8 percentage points, respectively.
The loss ratio for the three months ended June 30, 2025 improved compared to the ratio for the prior year period primarily due to less net adverse reserve development on prior accident years (excluding adverse prior year development that is subject to retroactive reinsurance accounting - see discussion above) which was $2.3 million or 1.6 points adverse in the three months ended June 30, 2025 compared to $10.7 million or 7.6 points adverse in the three months ended June 30, 2024. The adverse development in the prior year period included $9.7 million that was subject to the E&S ADC. The E&S ADC was effective January 1, 2024, but closed on July 2, 2024. As such, recoveries were recognized beginning in the third quarter of 2024. The premium adjustments associated with prior years including reinstatement premium increased the respective loss ratios by 1.2 and 0.6 percentage points.
The expense ratio increased from 23.1% in the prior year quarter to 25.3% in the current year quarter due to the impact of the premium adjustments associated with prior years including reinstatement premium, lower ceding commissions due to changes in reinsurance treaty structure, and higher expenses for outside consulting, software, and bad debts. The premium adjustments increased the segment expense ratio by 0.5 and 0.2 percentage points in the respective periods.
For the six months ended June 30, 2025 and 2024, the Excess and Surplus Lines segment produced underwriting profits of $23.4 million and $24.9 million (combined ratios of 91.6% and 91.3%), respectively. The underwriting results were impacted by $5.8 million and $1.2 million, respectively, of premium adjustments associated with prior years including reinstatement premium which reduced net written and net earned premiums, and underwriting profit. The premium adjustments increased the segment combined ratio by 1.9 and 0.4 in the respective six-month periods.
The six-month loss ratios include net reserve development on prior accident years (excluding adverse prior year development that is subject to retroactive reinsurance accounting - see discussion above) that was $2.3 million or 0.8 points adverse for the six months ended June 30, 2025 compared to $10.7 million or 3.7 points adverse in the six months ended June 30, 2024. The premium adjustments increased the segment loss ratio by 1.3 and 0.3 in the respective six-month periods.
The expense ratio increased from 23.1% for the six months ended June 30, 2024 to 26.0% in the corresponding current year period reflecting lower net earned premium, including the impact of the premium adjustments associated with prior years including reinstatement premium, lower ceding commissions due to changes in reinsurance treaty structure, and higher expenses for compensation, outside consulting, software, and bad debts. The premium adjustments increased the segment expense ratio by 0.6 and 0.1 percentage points in the respective six-month periods.
Specialty Admitted Insurance Segment
Results for the Specialty Admitted Insurance segment are as follows:
Three Months Ended
June 30,
%
Six Months Ended
June 30,
%
2025
2024
Change
2025
2024
Change
($ in thousands)
Gross written premiums
$
77,559
$
119,411
(35.0)
%
$
158,677
$
236,530
(32.9)
%
Net written premiums
$
9,345
$
19,752
(52.7)
%
$
22,222
$
40,499
(45.1)
%
Net earned premiums
$
11,239
$
22,746
(50.6)
%
$
26,113
$
48,814
(46.5)
%
Losses and loss adjustment expenses
(10,042)
(17,622)
(43.0)
%
(22,691)
(38,068)
(40.4)
%
Underwriting expenses
(2,618)
(1,708)
53.3
%
(5,149)
(6,544)
(21.3)
%
Underwriting profit
(1), (2)
$
(1,421)
$
3,416
—
$
(1,727)
$
4,202
—
Ratios:
Loss ratio
89.3
%
77.5
%
86.9
%
78.0
%
Expense ratio
23.3
%
7.5
%
19.7
%
13.4
%
Combined ratio
112.6
%
85.0
%
106.6
%
91.4
%
Accident year loss ratio
83.1
%
77.5
%
84.7
%
78.9
%
(1)
Underwriting Profit is a non-GAAP Measure. See “Reconciliation of Non-GAAP Measures.”
(2)
Underwriting results include gross fee income of $3.9 million
and
$8.3 million for the three and six months ended June 30, 2025 respectively ($5.6 million
and $10.9 million in the respective prior year periods).
The Specialty Admitted Insurance segment reported underwriting losses of $1.4 million and $1.7 million in the three and six months ended June 30, 2025, respectively, compared to underwriting profits of $3.4 million and $4.2 million in the three and six months ended June 30, 2024, respectively. Net earned premium and fee income declined compared to the three and six month periods in the prior year due to the non-renewal of several programs, reflective of the Company's strategy to remain opportunistic in the current market environment and manage the segment to retain minimal risk. The segment loss ratios were impacted by net development in our loss estimates for prior accident years that was $700,000 and $579,000 adverse in the three and six months ended June 30, 2025, respectively, compared to $4,000 and $442,000 favorable in the three and six months ended June 30, 2024, respectively. The segment expense ratios in the prior year benefited from certain sliding scale and other adjustments on certain programs which lowered commission expense and the segment expense ratio in the prior year.
Corporate and Other Segment
Other operating expenses for the Corporate and Other segment include personnel costs associated with the Bermuda and U.S. holding companies, professional fees, long-term incentive compensation (including share-based compensation) for the full Company, public company and various other corporate expenses. The expenses are included in our calculation of consolidated underwriting profit, and in our consolidated expense ratio and combined ratio. Total operating expenses of the Corporate and Other segment were $8.2 million and $18.9 million for the three and six months ended
June 30, 2025, respectively ($8.6 million and $19.8 million in the respective prior year periods). The reduction in operating expenses from the prior year periods was primarily attributable to reduced compensation expenses and lower insurance and financial audit expenses.
Net investment income was $20.5 million and $40.5 million for the three and six months ended
June 30, 2025, respectively ($24.9 million and $47.6 million in the respective prior year periods). The Company's private investments generated income of $986,000 and $1.2 million for the three and six months ended
June 30, 2025, respectively (income of $1.9 million and $1.8 million in the respective prior year periods). Excluding private investments, our net investment income for the three and six months ended June 30, 2025 decreased 15.2% and 14.1%, respectively, from the three and six month periods in the prior year principally due to lower invested assets following the funding of strategic initiatives during the last half of 2024 including the reinsurance premiums paid to enter the E&S ADC and the E&S Top Up ADC, as well as lower yields. The average duration of our portfolio excluding restricted cash equivalents was 3.5 years at June 30, 2025.
Major categories of the Company’s net investment income are summarized as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
($ in thousands)
Fixed maturity securities
$
12,919
$
12,628
$
25,151
$
25,493
Bank loan participations
3,124
4,624
6,319
9,080
Equity securities
1,445
1,632
2,704
3,546
Other invested assets
986
1,909
1,186
1,764
Cash, cash equivalents, restricted cash equivalents and short-term investments
2,979
5,064
7,051
9,504
Gross investment income
21,453
25,857
42,411
49,387
Investment expense
(937)
(926)
(1,887)
(1,824)
Net investment income
$
20,516
$
24,931
$
40,524
$
47,563
The following table summarizes our annualized gross investment yields:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
Cash and invested assets
4.4
%
4.8
%
4.3
%
4.7
%
Fixed maturity securities
4.2
%
5.0
%
4.3
%
5.0
%
Of our total cash and invested assets of $1,936.5 million at June 30, 2025 (excluding restricted cash equivalents), $220.0 million represents the cash and cash equivalents portion of the portfolio. The majority of the portfolio, or $1,300.2 million, is comprised of fixed maturity securities that are classified as available-for-sale and carried at fair value with unrealized gains and losses on these securities reported, net of applicable taxes, as a separate component of accumulated comprehensive income (loss). Also included in our investments are $158.9 million of bank loan participations, $88.0 million of equity securities, $111.2 million of short-term investments, and $58.1 million of other invested assets.
Bank loan participations generally provide a higher yield than our portfolio of fixed maturity securities and are primarily senior, secured floating-rate debt rated “BB”, “B”, or “CCC” by Standard & Poor’s or an equivalent rating from another nationally recognized statistical rating organization, and are therefore below investment grade. Bank loans include assignments of and participations in performing and non-performing senior corporate debt generally acquired through primary bank syndications and in secondary markets. They consist of, but are not limited to, term loans, the funded and unfunded portions of revolving credit facilities, and similar loans and investments.
Bank loan participations are measured at fair value pursuant to the Company's election of the fair value option, and changes in unrealized gains and losses in bank loan participations are reported in our income statement as net realized and unrealized gains (losses) on investments.
At June 30, 2025 and December 31, 2024, the fair market value of these securities was $158.9 million and $142.4 million, respectively.
For the six months ended June 30, 2025, the Company recognized net realized and unrealized investment losses of $1.7 million ($352,000 of net realized and unrealized investment losses for the three months ended June 30, 2025), including $767,000 of net unrealized gains on bank loan participations, $68,000 of net unrealized gains for the change in the fair value of equity securities, $2.8 million of net realized investment losses on the sale of bank loan participations, $245,000 of net realized investment gains on the sale of equity securities, and $25,000 of net realized investment gains on the sale of fixed maturity securities.
For the six months ended June 30, 2024, the Company recognized net realized and unrealized investment gains of $2.3 million ($2.3 million of net realized and unrealized losses for the three months ended June 30, 2024), including $394,000 of net unrealized losses on bank loan participations, $3.1 million of net unrealized gains for the change in the fair value of equity securities, $730,000 of net realized investment losses on the sale of bank loan participations, $1.4 million of net realized investment gains on the sale of equity securities, and $1.1 million of net realized investment losses on the sale of fixed maturity securities.
In conjunction with its outside investment managers, the Company performs quarterly reviews of all securities within its investment portfolio to determine whether any impairment has occurred. As a result of this review, management concluded that there were no credit-related impairments of fixed maturity securities at June 30, 2025, December 31, 2024, or June 30, 2024. At June 30, 2025, 100.0% of the Company’s fixed maturity security portfolio was rated “BBB-” or better (“investment grade”) by Standard & Poor’s or received an equivalent rating from another nationally recognized rating agency.
Management does not intend to sell available-for-sale securities in an unrealized loss position, and it is not “more likely than not” that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs.
The amortized cost and fair value of our available-for-sale fixed maturity securities were as follows:
June 30, 2025
December 31, 2024
Cost or
Amortized
Cost
Fair
Value
% of
Total
Fair Value
Cost or
Amortized
Cost
Fair
Value
% of
Total
Fair Value
($ in thousands)
Fixed maturity securities, available-for-sale:
State and municipal
$
222,687
$
199,490
15.3
%
$
223,009
$
196,564
16.5
%
Residential mortgage-backed
415,523
397,110
30.5
%
352,064
326,227
27.4
%
Corporate
545,680
528,508
40.7
%
503,610
475,485
40.0
%
Commercial mortgage and asset-backed
162,123
156,817
12.1
%
178,238
170,458
14.3
%
U.S. Treasury securities and obligations guaranteed by the U.S. government
18,442
18,292
1.4
%
21,416
20,999
1.8
%
Total fixed maturity securities, available-for-sale
$
1,364,455
$
1,300,217
100.0
%
$
1,278,337
$
1,189,733
100.0
%
The following table sets forth the composition of the Company’s portfolio of available-for-sale fixed maturity securities by rating as of
June 30, 2025
:
The amortized cost and fair value of our available-for-sale investments in fixed maturity securities summarized by contractual maturity are as follows:
June 30, 2025
Amortized
Cost
Fair
Value
% of
Total Value
($ in thousands)
Due in:
One year or less
$
31,869
$
31,588
2.4
%
After one year through five years
392,344
385,220
29.6
%
After five years through ten years
217,668
205,185
15.8
%
After ten years
144,928
124,297
9.6
%
Residential mortgage-backed
415,523
397,110
30.5
%
Commercial mortgage and asset-backed
162,123
156,817
12.1
%
Total
$
1,364,455
$
1,300,217
100.0
%
Other Income and Expense
Other income and (expense) included the following:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
($ in thousands)
Non-operating expenses
$
(1,008)
$
(2,098)
$
(1,571)
$
(2,830)
Broker incentive rebates - Excess and Surplus Lines
1,163
993
1,998
1,701
Other miscellaneous income
79
200
162
403
Other income and (expense)
$
234
$
(905)
$
589
$
(726)
The n
on-operating expenses above primarily consist of legal and other professional fees and other expenses related to various strategic initiatives and litigation that the Company is involved in.
Interest Expense
Interest expense was $5.8 million and $11.3 million for the three and six
months ended June 30, 2025, respectively (
$6.3 million
and $12.8 million in the respective prior year periods)
.
The lower expense in the current year periods is primarily attributable to lower interest rates. See “—Liquidity and Capital Resources—Sources and Uses of Funds” for more information regarding our senior bank debt facilities and trust preferred securities.
Amortization of Intangibles and Impairment of Intangible Assets
The Company recorded $91,000 of amortization of intangible assets in each of the three months ended
June 30, 2025
and 2024 ($182,000 in each of the six months ended
June 30, 2025
and 2024 ).
Income Tax Expense
Our effective tax rate fluctuates from period to period based on the relative mix of income from continuing operations reported by country and the respective tax rates imposed by each tax jurisdiction. Statutory tax rates are 0% and 21% for Bermuda and the U.S. For the three and six
months ended June 30, 2025
, our effective tax rate on income from continuing operations was 30.1% and 31.0%, respectively (28.3% and 28.5% in the respective prior year periods). The Company does not receive a U.S. tax deduction for losses at JRG Holdings, our only Bermuda entity. JRG Holdings had losses in all periods presented primarily due to holding company expenses and interest expense. For U.S.-sourced income, the Company’s U.S. federal income tax expense differs from the amounts computed by applying the federal statutory income tax rate to income before taxes due primarily to interest income on tax-advantaged state and municipal securities, dividends received income, and excess tax benefits and expenses on share based compensation.
Reserves
An indicator of reserve strength that we monitor is the percentage of our gross and net loss reserves that are comprised of incurred but not reported (“IBNR”) reserves.
The Company’s gross reserve for losses and loss adjustment expenses at June 30, 2025 was $3,076.5 million. Of this amount, 74.4% relates to amounts that are IBNR. This amount was 73.3% at December 31, 2024. The Company’s gross reserves for losses and loss adjustment expenses by segment are summarized as follows:
Gross Reserves at June 30, 2025
Case
IBNR
Total
($ in thousands)
Excess and Surplus Lines
$
435,091
$
1,821,392
$
2,256,483
Specialty Admitted Insurance
352,404
467,611
820,015
Total
$
787,495
$
2,289,003
$
3,076,498
At June 30, 2025, the amount of net reserves (prior to the $1.5 million allowance for uncollectible reinsurance recoverables) of $1,089.2 million that related to IBNR was 64.1%. This amount was 63.5% at December 31, 2024. The Company’s net reserves for losses and loss adjustment expenses by segment are summarized as follows:
Net Reserves at June 30, 2025
Case
IBNR
Total
($ in thousands)
Excess and Surplus Lines
$
335,232
$
620,511
$
955,743
Specialty Admitted Insurance
56,290
77,148
133,438
Total
$
391,522
$
697,659
$
1,089,181
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Funds
Our sources of funds consist primarily of premiums written, investment income, reinsurance recoveries, proceeds from sales and redemptions of investments, borrowings on our credit facilities, and the issuance of common shares and Series A Preferred Shares. We use operating cash flows primarily to pay operating expenses, losses and loss adjustment expenses, reinsurance premiums, and income taxes. Cash flow from operations may differ substantially from net income. The potential for a large claim under an insurance contract means that substantial and unpredictable payments may need to be made within relatively short periods of time.
Change in restricted cash equivalents (operating activities)
616
(44,486)
Change in cash, cash equivalents, and restricted cash equivalents
$
(141,688)
$
340,537
Cash used in operating activities excluding restricted cash equivalents was $26.9 million for the six months ended June 30, 2025. This compares to cash provided by operating activities excluding restricted cash equivalents of $59.9 million for the six months ended June 30, 2024 (including cash provided by operating activities from continuing operations excluding restricted cash equivalents of $85.0 million and cash used in operating activities of discontinued operations of $25.1 million). The current year operating activities were impacted by timing of reinsurance settlements during the first quarter and lower premium collections in the Specialty Admitted Insurance segment due to the non-renewal of several programs.
Cash used in investing activities of $133.7 million for the six months ended June 30, 2025 reflects efforts to enhance the yield in our investment portfolio by investing available cash and cash equivalents into higher yielding investments. Cash provided by investing activities of $356.6 million for the six months ended June 30, 2024 included $96.4 million of proceeds received from the sale of JRG Re (net of JRG Re's cash balances sold) and $198.0 million of proceeds from the sales of fixed maturities to provide funding for the premium due under the E&S ADC agreement. Cash and cash equivalents excluding
restricted cash equivalents comprised 11.4% and 31.1% of total cash and invested assets at June 30, 2025 and 2024, respectively. Cash used in investing activities from continuing operations was $197.1 million and cash provided by investing activities of discontinued operations was $63.1 million in the prior year period.
Cash provided by financing activities of $18.3 million for the six months ended June 30, 2025 includes a $25.0 million borrowing under the Previous Credit Agreement (as defined below), $1.1 million of issuance costs paid upon the Company's entry into the Credit Agreement (as defined below), $1.1 million of dividends paid to common shareholders, $3.9 million of dividends paid on the Series A Preferred Shares, and $550,000 of payroll taxes withheld and remitted on net settlement of RSUs. Cash used in financing activities of $31.5 million for the six months ended June 30, 2024 includes a $21.5 million repayment of an unsecured loan, $3.9 million of dividends paid to common shareholders, $5.3 million of dividends paid on the Series A Preferred Shares, and $837,000 of payroll taxes withheld and remitted on net settlement of RSUs.
The activity in restricted cash equivalents for the six months ended June 30, 2025 and 2024 relates to a former insured, per the terms of a collateral trust. See
Amounts Recoverable from an Indemnifying Party and Reinsurer on Legacy Commercial Auto Book
below.
Dividends
We are organized as a Bermuda holding company with our operations conducted by our wholly-owned subsidiaries. Accordingly, our holding company may receive cash through loans from banks, issuance of equity and debt securities, corporate service fees or dividends received from our subsidiaries and/or other transactions. Our U.S. holding company may receive cash in a similar manner and also through payments from our subsidiaries pursuant to our U.S. consolidated tax allocation agreement.
The payment of dividends by our subsidiaries to us is limited by statute. In general, the laws and regulations applicable to our domestic insurance subsidiaries limit the aggregate amount of dividends or other distributions that they may declare or pay within any 12-month period without advance regulatory approval. Generally, the limitations are based on the greater of statutory net income for the preceding year or 10.0% of statutory surplus at the end of the preceding year. In addition, insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels and could refuse to permit the payment of dividends calculated under any applicable formula. See “Item 1. Business—U.S. Insurance Regulation—State Regulation” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 for additional information. The maximum amount of dividends available to the U.S. holding company from our U.S. insurance subsidiaries during 2025 without regulatory approval is $64.3 million.
Holders of the Series A Preferred Shares are entitled to a dividend at the rate of 7% of the $1,000 liquidation preference per share (the “Liquidation Preference”) per annum, paid in cash, in-kind in common shares or in Series A Preferred Shares, at our election. On October 1, 2029, and each five-year anniversary thereafter, the dividend rate will reset to a rate equal to the five-year U.S. treasury rate plus 5.2%, provided that the dividend rate shall not exceed 8.0%. Dividends accrue and are payable quarterly. Cash dividends of $3.9 million and $5.3 million were paid in the six months ended June 30, 2025 and 2024, respectively.
At June 30, 2025, the Bermuda holding company had $20.8 million of cash and cash equivalents. The U.S. holding company had $8.9 million of cash and invested assets, comprised of cash and cash equivalents of $5.3 million, equities of $3.1 million and other invested assets of $464,000, which are not subject to regulatory restrictions. Additionally, our U.K. intermediate holding company had no invested assets and cash of less than ten thousand dollars at June 30, 2025.
Credit Agreements
On June 12, 2025, JRG Holdings entered into a Credit Agreement (the “Credit Agreement”). The Credit Agreement replaced JRG Holdings’ previous Third Amended and Restated Credit Agreement dated as of July 7, 2023, as amended (the “Previous Credit Agreement”), that provided for a $212.5 million unsecured revolving credit facility and a $45.0 million secured revolving credit facility.
The Credit Agreement provides for a $212.5 million unsecured revolving credit facility available for general corporate purposes and matures on June 12, 2028. Following the sale of JRG Re, the Company no longer has a need for the secured revolving credit facility provided by the Previous Credit Agreement. The interest rates applicable to the loans under the Credit Agreement are generally based on SOFR plus a specified margin based on the Company’s Leverage Ratio (as defined in the Credit Agreement). In addition, JRG Holdings will pay an unused facility fee on each lender’s commitment.
At
June 30, 2025
, JRG Holdings had a drawn balance of $210.8 million outstanding on the unsecured revolver of the Credit Agreement, including $25.0 million previously borrowed on January 27, 2025 under the Previous Credit Agreement which was contributed to our regulated insurance entities.
The Credit Agreement provides for an accordion feature that permits JRG Holdings to request that one or more lenders (without the consent of the other lenders) or new financial institutions (with the consent of the Administrative Agent) provide it with increases in the credit facility of up to an aggregate of $30.0 million, subject to satisfaction of certain conditions.
The Credit Agreement contains customary representations and warranties, affirmative and negative covenants and events of default. The Credit Agreement also includes financial covenants, including a maximum leverage ratio and minimum consolidated net worth, risk-based capital ratio and financial strength rating requirements
with which the Company was in compliance at
June 30, 2025.
In connection with the Credit Agreement, James River Group Holdings UK Limited (“James River UK”), a private limited company incorporated under the Laws of England and Wales and a direct wholly owned subsidiary of JRG Holdings, and James River Group, Inc. (“James River Group”), a Delaware corporation and an indirect wholly owned subsidiary of JRG Holdings, each entered into a Continuing Guaranty of Payment dated June 12, 2025 (each, a “Payment Guaranty”). Pursuant to its respective Payment Guaranty, each of James River UK and James River Group guarantees the payment and performance of the obligations of JRG Holdings under the Credit Agreement and other loan documents.
Senior Debt and Trust Preferred Securities
On May 26, 2004, we issued $15.0 million of senior debt due April 29, 2034. The senior debt is not redeemable by the holder or subject to sinking fund requirements. Interest accrues quarterly and is payable in arrears at a floating rate per annum equal to the 3-month SOFR plus 4.11%. This senior debt is redeemable at par prior to its stated maturity at our option in whole or in part. The terms of the senior debt contain certain covenants, with which we are in compliance at June 30, 2025, and which, among other things, restrict our ability to issue senior indebtedness secured by our U.S. holding company’s common stock or its subsidiaries’ capital stock or to issue shares of its subsidiaries’ capital stock.
From May 2004 through January 2008, we sold trust preferred securities through five Delaware statutory trusts sponsored and wholly-owned by the Company or its subsidiaries. Each trust used the net proceeds from the sale of its trust preferred securities to purchase our floating-rate junior subordinated debt.
The following table summarizes the nature and terms of the junior subordinated debt and trust preferred securities outstanding at June 30, 2025 (including the Company’s repurchases of a portion of these trust preferred securities):
James River
Capital
Trust I
James River
Capital
Trust II
James River
Capital
Trust III
James River
Capital
Trust IV
Franklin
Holdings II
(Bermuda)
Capital
Trust I
($ in thousands)
Issue date
May 26, 2004
December 15, 2004
June 15, 2006
December 11, 2007
January 10, 2008
Principal amount of trust preferred securities
$7,000
$15,000
$20,000
$54,000
$30,000
Principal amount of junior subordinated debt
$7,217
$15,464
$20,619
$55,670
$30,928
Carrying amount of junior subordinated debt net of repurchases
$7,217
$15,464
$20,619
$44,827
$15,928
Maturity date of junior subordinated debt, unless accelerated earlier
May 24, 2034
December 15, 2034
June 15, 2036
December 15, 2037
March 15, 2038
Trust common stock
$217
$464
$619
$1,670
$928
Interest rate, per annum
Three-Month
SOFR plus
4.3%
Three-Month
SOFR plus
3.7%
Three-Month
SOFR plus
3.3%
Three-Month
SOFR plus
3.4%
Three-Month
SOFR plus
4.3%
All of the junior subordinated debt is currently redeemable at 100.0% of the unpaid principal amount at our option.
The junior subordinated debt contains certain covenants with which we are in compliance as of June 30, 2025.
At June 30, 2025 and December 31, 2024, the Company's leverage ratio was 28.5% and 26.6%, respectively. The leverage ratio is defined in the Credit Agreement as the ratio of adjusted consolidated debt to total capital. Adjusted consolidated debt treats trust preferred securities as equity capital up to 15% of total capital. The Series A Preferred Shares represent equity capital for purposes of the leverage ratio calculation under the credit agreements. Total capital is defined as total debt plus tangible equity excluding accumulated other comprehensive income. The maximum leverage ratio permitted by the agreements is 35.0%.
James River Insurance has access to certain credit products including advances through its membership in the Federal Home Loan Bank. Any advances would be in the form of collateralized short-term borrowings not to exceed 30% of the Company's total assets.
Our insurance segments enter into reinsurance contracts to limit our exposure to potential losses arising from large risks, to protect against the aggregation of several risks in a common loss occurrence, and to provide additional capacity for growth. Our reinsurance is contracted under excess of loss and proportional quota share reinsurance contracts. In excess of loss reinsurance, the reinsurer agrees to assume all or a portion of the ceding company’s losses in excess of a specified amount. The premiums payable to the reinsurer are negotiated by the parties based on their assessment of the amount of risk being ceded to the reinsurer because the reinsurer does not share proportionately in the ceding company’s losses. In proportional quota share reinsurance, the reinsurer agrees to assume a specified percentage of the ceding company’s losses arising out of a defined class of business in exchange for a corresponding percentage of premiums. The Company also utilizes facultative reinsurance to reduce the amount of exposure it retains on individual accounts according to its guidelines for accepting risk across various industry segments, locations and types of exposure. For the six months ended June 30, 2025 and 2024, our net premium retention was 45.2% and 43.0%, respectively.
The following is a summary of our Excess and Surplus Lines segment’s ceded reinsurance in place as of June 30, 2025:
Line of Business
Company Retention
Casualty
Specialty Casualty
Up to $3.2 million per occurrence.
(1)
Primary Casualty
Up to $1.38 million per occurrence.
(2)
Excess Casualty
Up to $1.98 million per occurrence.
Property
Excess Property
Up to $5.0 million per risk.
(3)
(1) Excluding Excess Casualty.
(2) Total exposure to any one claim is generally $694,000.
(3) The property catastrophe reinsurance treaty has a limit of $22.0 million per event with one reinstatement.
We use catastrophe modeling software to analyze the risk of severe losses from hurricanes and earthquakes on our exposure. We utilize the model in our risk selection, pricing, and to manage our overall portfolio probable maximum loss (“PML”) accumulations. A PML is an estimate of the amount we would expect to pay in any one catastrophe event within a given annual probability of occurrence (i.e. a return period or loss exceedance probability).
In our Excess and Surplus Lines segment, we write a small book of excess property insurance, but we do not write primary property insurance. The Excess and Surplus Lines segment has a specific proportional quota share treaty in effect to cover property risks. The proportional quota share treaty along with facultative reinsurance helps ensure that our net retained limit per risk will be $5.0 million or less.
Also in our Excess and Surplus Lines segment, a specialty casualty treaty providing $9.0 million in excess of $2.0 million coverage is subject to reinstatement premiums for treaty years spanning July 1, 2017 through July 1, 2022.
Based upon the property catastrophe modeling of our Excess and Surplus Lines and Specialty Admitted segments, it would take an event greater than the 1 in 1,000 year PML to exhaust our $22.0 million property catastrophe reinsurance. In the event of a catastrophe loss exhausting our $22.0 million property catastrophe reinsurance, we estimate our pre-tax cost would not exceed 2.5% of shareholders’ equity, including reinstatement premiums and net retentions. In addition to this retention, we would retain any losses in excess of our reinsurance coverage limits.
The Commercial Auto LPT with Aleka reinsures substantially all of the Excess and Surplus Lines segment’s legacy portfolio of commercial auto policies previously issued to Rasier. See “
Amounts Recoverable from an Indemnifying Party and Reinsurer on Legacy Commercial Auto Book
” below for further information on this reinsurance agreement.
The E&S ADC with State National applies to James River’s Excess & Surplus Lines segment casualty portfolio losses attaching to premium earned during 2010-2023 (both years inclusive), excluding, among others, losses related to commercial auto policies issued to a former large insured or its affiliates. See “
Combined Loss Portfolio Transfer and Adverse Development Cover
” above for further information on this reinsurance agreement.
The E&S Top Up ADC with Enstar, through its subsidiary Cavello Bay Reinsurance Limited, reinsures 100% of the losses associated with James River’s Excess & Surplus Lines segment portfolio losses attaching to premium earned during 2010-2023 (both years inclusive). This agreement excludes losses related to commercial auto policies issued to a former large insured or its affiliates. It is subject to a retention by James River of $1,183.7 million (the limit of the E&S ADC) and up to an aggregate limit of $75.0 million. See “
Enstar Strategic Partnership
” above for further information on this reinsurance agreement.
The following is a summary of our Specialty Admitted Insurance segment’s ceded reinsurance in place as of June 30, 2025:
Line of Business
Coverage
Casualty
Auto Programs
All programs are quota share coverage for 100% of limits up to $1.0 million liability and $1.0 million physical damage per occurrence; except for one program with a primary limit of $750,000 liability.
General Liability & Professional Liability – Programs
Quota share coverage for 100% of limits up to $2.0 million per occurrence.
Umbrella and Excess Casualty - Programs
Quota share coverage for 100% of limits up to $10.0 million per occurrence, and 100% of excess of loss coverage for limits up to $5.0 million in excess of $10.0 million.
Property
Property within Package - Programs
Quota share coverage for 100% of limits up to $40.0 million per risk.
Aviation Programs
Quota share coverage for 82.5% of limits up to $25.0 million liability, $5.0 million hull, and $5.0 million spares per occurrence, each aircraft; and excess of loss coverage for up to $7.7 million excess of $175,000 of our 17.5% share of the quota share each occurrence.
Our Specialty Admitted Insurance segment purchases reinsurance for at least 62.5% of the exposed limits on specialty admitted property-casualty business. While the segment focuses on casualty business, incidental property risk is incurred in the fronting and program business. The segment is covered for $22.0 million in excess of $3.0 million per occurrence to manage its property exposure to an approximate 1 in 1,000 year PML.
In the aggregate, we believe our pre-tax group-wide PML from a 1 in 1,000 year property catastrophe event would not exceed 2.5% of shareholders’ equity, inclusive of reinstatement premiums payable.
The Company’s insurance segments remain liable to policyholders if its reinsurers are unable to meet their contractual obligations under applicable reinsurance agreements. We establish an allowance for credit losses for our current estimate of uncollectible reinsurance recoverables. At June 30, 2025, the allowance for credit losses on reinsurance recoverables was $1.5 million. To minimize exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk. The Company generally seeks to purchase reinsurance from reinsurers with A.M. Best financial strength ratings of “A-” (Excellent) or better. The Company’s reinsurance contracts generally require reinsurers that are not authorized as reinsurers under U.S. state insurance regulations or that experience rating downgrades from rating agencies below specified levels to fund their share of the Company’s ceded outstanding losses and loss adjustment expense reserves, typically through the use of irrevocable and unconditional letters of credit. In fronting arrangements, which the Company conducts through its Specialty Admitted Insurance segment, we are subject to credit risk with regard to insurance companies who act as reinsurers for us in such arrangements. We require collateral, in the form of a trust arrangement or letter of credit, to secure the obligations of the insurance entity for whom we are fronting.
At June 30, 2025, we had reinsurance recoverables on unpaid losses of $1,985.8 million (net of a $1.5 million allowance for credit losses) and reinsurance recoverables on paid losses of $123.0 million, and all material recoverable amounts were from companies with A.M. Best ratings of “A-” (Excellent) or better, or are collateralized by the reinsurer for our benefit through letters of credit or funds on deposit in trust accounts.
Amounts Recoverable from an Indemnifying Party and Reinsurer on Legacy Commercial Auto Book
James River previously issued a set of commercial auto insurance contracts (the “Rasier Commercial Auto Policies”) to Rasier under which James River pays losses and loss adjustment expenses on the contracts. James River has indemnity agreements with Rasier (non-insurance entities) (collectively, the “Indemnity Agreements”) and is contractually entitled to reimbursement for the portion of the losses and loss adjustment expenses paid on behalf of Rasier under the Rasier Commercial Auto Policies and other expenses incurred by James River. In addition, on September 27, 2021, James River entered into the Commercial Auto LPT with Aleka to reinsure substantially all of the Rasier Commercial Auto Policies for which James River is not otherwise indemnified by Rasier under the Indemnity Agreements.
Each of Rasier and Aleka are required to post collateral equal to 102% of James River's estimate of the respective party's obligations in trusts pursuant to the terms of the Indemnity Agreements and the Commercial Auto LPT, respectively. At June 30, 2025, the total balance of collateral securing Rasier's obligations under the Indemnity Agreements was $55.3 million
and Aleka's obligations under the Commercial Auto LPT was $26.5 million. At June 30, 2025, the total reinsurance recoverables under the Commercial Auto LPT was $24.1 million.
While the Commercial Auto LPT brings economic finality to substantially all of the Rasier Commercial Auto Policies, the Company has credit exposure to Rasier and Aleka under the Indemnity Agreements and the Commercial Auto LPT if the estimated losses and expenses of the Rasier Commercial Auto Policies grow at a faster pace than the growth in our collateral balances. In addition, we have credit exposure if our estimates of future losses and loss adjustment expenses and other amounts recoverable under the Indemnity Agreements and the Commercial Auto LPT, which are the basis for establishing the collateral balances, are lower than actual amounts paid or payable. The amount of our credit exposure in any of these instances could be material. To mitigate these risks, we closely and frequently monitor our exposure compared to our collateral held, and we request additional collateral in accordance with the terms of the Commercial Auto LPT and Indemnity Agreements when our analysis indicates that we have uncollateralized exposure.
Ratings
The A.M. Best Company financial strength rating for our U.S. insurance subsidiaries is “A-” (Excellent) with a negative outlook. This rating reflects A.M. Best’s opinion of our insurance subsidiaries’ financial strength, operating performance and ability to meet obligations to policyholders and is not an evaluation directed towards the protection of investors. The A- rating is the fourth highest rating of the thirteen ratings issued by A.M. Best and is assigned to insurers that have, in A.M. Best’s opinion, an excellent ability to meet their ongoing obligations to policyholders.
The financial strength ratings assigned by A.M. Best have an impact on the ability of our regulated subsidiaries to attract and retain agents and brokers and on the risk profiles of the submissions for insurance that our subsidiaries receive. We believe the “A-” (Excellent) ratings assigned to our U.S. insurance subsidiaries allow our subsidiaries to actively pursue relationships with the agents and brokers identified in their marketing plans.
Series A Preferred Shares
The Company closed on the issuance and sale of 150,000 Series A Preferred Shares on March 1, 2022 for an aggregate purchase price of $150.0 million, or $1,000 per share, in a private placement. The Series A Preferred Shares are convertible into the Company’s common shares at the option of the holder at any time, or at the Company’s option under certain circumstances. Dividends on the Series A Preferred Shares accrue quarterly at the rate of 7% of the Liquidation Preference per annum, which may be paid in cash, in-kind in common shares or in Series A Preferred Shares, at the Company’s election.
On November 11, 2024, the Company amended the Certificate of Designations setting forth the terms of the Series A Preferred Shares to, among other things, convert 37,500 outstanding Series A Preferred Shares with a liquidation value of $37.5 million to common shares at a per share price of $6.40. Following the conversion, 112,500 Series A Preferred Shares remain outstanding.
EQUITY
Total common shares outstanding increased from 45,644,318 at December 31, 2024 to 45,895,335 at June 30, 2025, reflecting 251,017 common shares issued in the six months ended June 30, 2025 related to vesting of RSUs.
Share Based Compensation Expense
The Company recognized $834,000 and $3.5 million of share based compensation expense in the three and six months ended June 30, 2025, respectively ($1.6 million and $4.2 million in the respective prior year periods). As of June 30, 2025, the Company had $6.9 million of unrecognized share based compensation expense expected to be charged to earnings over a weighted-average period of 2.0 years.
Outstanding RSUs granted to employees generally vest ratably over a three-year vesting period in the case of time-vest RSUs and cliff vest at the end of a three-year performance period in the case of PRSUs. RSUs granted to non-employee directors generally have a one year vesting period. The RSUs granted in 2025 and 2024 include 620,108 and 231,492 PRSU awards, respectively. Initial PRSU awards are granted at the 100% target performance level. The Company projects the level of achievement for each award during the performance period and periodically adjusts the number of outstanding awards to reflect the number of awards expected to vest.
Options
At December 31, 2023, the Company had 74,390 options outstanding with an average weighted exercise price of $42.17. The options lapsed in the six months ended June 30, 2024, after which, there have been no options outstanding.
The following table provides the underwriting performance ratios of the Company's continuing operations inclusive of the business subject to retroactive reinsurance accounting. There is no economic impact to the Company over the life of a retroactive reinsurance contract so long as any additional losses subject to the contract are within the limit of the contract and the counterparty performs under the contract. Retroactive reinsurance accounting is not indicative of our current and ongoing operations. Management believes that providing loss ratios and combined ratios on business not subject to retroactive reinsurance accounting gives the users of our financial statements useful information in evaluating our current and ongoing operations.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
Excess and Surplus Lines:
Loss Ratio
66.4
%
72.3
%
65.6
%
68.2
%
Impact of retroactive reinsurance
6.5
%
(2.6)
%
2.6
%
(2.7)
%
Loss Ratio including impact of retroactive reinsurance
72.9
%
69.7
%
68.2
%
65.5
%
Combined Ratio
91.7
%
95.4
%
91.6
%
91.3
%
Impact of retroactive reinsurance
6.5
%
(2.6)
%
2.6
%
(2.7)
%
Combined Ratio including impact of retroactive reinsurance
98.2
%
92.8
%
94.2
%
88.6
%
Consolidated:
Loss Ratio
68.1
%
73.0
%
67.4
%
69.6
%
Impact of retroactive reinsurance
6.1
%
(2.3)
%
2.4
%
(2.3)
%
Loss Ratio including impact of retroactive reinsurance
74.2
%
70.7
%
69.8
%
67.3
%
Combined Ratio
98.6
%
99.3
%
99.1
%
97.2
%
Impact of retroactive reinsurance
6.1
%
(2.3)
%
2.4
%
(2.3)
%
Combined Ratio including impact of retroactive reinsurance
See “Key Metrics” above for descriptions of why management believes the following Non-GAAP measures provide useful information about our financial condition and results of operation.
Reconciliation of Underwriting Profit
We define underwriting profit as net earned premiums and gross fee income (in specific instances when the Company is not retaining insurance risk) less losses and loss adjustment expenses on business from continuing operations not subject to retroactive reinsurance accounting and other operating expenses. Other operating expenses include the underwriting, acquisition, and insurance expenses of the operating segments and, for consolidated underwriting profit, the expenses of the Corporate and Other segment. Our definition of underwriting profit may not be comparable to that of other companies.
The following table reconciles the underwriting profit of the operating segments by individual segment to consolidated income from continuing operations before income taxes:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025
2024
2025
2024
(in thousands)
Underwriting profit (loss) of the operating segments:
Excess and Surplus Lines
$
11,707
$
6,427
$
23,365
$
24,918
Specialty Admitted Insurance
(1,421)
3,416
(1,727)
4,202
Total underwriting profit of operating segments
10,286
9,843
21,638
29,120
Other operating expenses of the Corporate and Other segment
(8,222)
(8,624)
(18,853)
(19,761)
Underwriting profit
(1)
2,064
1,219
2,785
9,359
Losses and loss adjustment expenses - retroactive reinsurance
(9,239)
3,684
(7,311)
7,686
Net investment income
20,516
24,931
40,524
47,563
Net realized and unrealized (losses) gains on investments
(352)
(2,305)
(1,723)
2,278
Other income and expenses
234
(905)
589
(726)
Interest expense
(5,805)
(6,344)
(11,346)
(12,829)
Amortization of intangible assets
(91)
(91)
(182)
(182)
Income from continuing operations before income taxes
$
7,327
$
20,189
$
23,336
$
53,149
(1)
Included in underwriting results for the three and six months ended June 30, 2025 is gross fee income of $3.9 million and $8.3 million, respectively ($5.6 million and $10.9 million in the respective prior year periods).
Adjusted net operating income is defined as income available to common shareholders excluding a) income (loss) from discontinued operations, b) the impact of retroactive reinsurance accounting, c) net realized and unrealized gains (losses) on investments, d) certain non-operating expenses such as professional service fees related to certain lawsuits, various strategic initiatives, and the filing of registration statements for the offering of securities, e) severance costs associated with terminated employees, and f) deemed dividends recorded with the amendment of the Series A Preferred Shares. Adjusted net operating income should not be viewed as a substitute for net income calculated in accordance with GAAP, and our definition of adjusted net operating income may not be comparable to that of other companies.
Our income available to common shareholders reconciles to our adjusted net operating income as follows:
Three Months Ended June 30,
2025
2024
Income
Before
Taxes
Net
Income
Income
Before
Taxes
Net
Income
($ in thousands)
Income available to common shareholders
$
4,997
$
2,790
$
10,711
$
5,000
Loss from discontinued operations
361
361
6,853
6,853
Losses and loss adjustment expenses - retroactive reinsurance
9,239
7,299
(3,684)
(2,910)
Net realized and unrealized investment losses (gains)
352
278
2,305
1,821
Other expenses
1,008
965
2,098
1,900
Adjusted net operating income
$
15,957
$
11,693
$
18,283
$
12,664
Six Months Ended June 30,
2025
2024
Income
Before
Taxes
Net
Income
Income
Before
Taxes
Net
Income
($ in thousands)
Income available to common shareholders
$
17,623
$
10,395
$
32,941
$
17,778
Loss from discontinued operations
1,775
1,775
14,958
14,958
Losses and loss adjustment expenses - retroactive reinsurance
7,311
5,776
(7,686)
(6,072)
Net realized and unrealized investment losses (gains)
Tangible Equity (per Share) and Tangible Common Equity (per Share)
Tangible equity is defined as shareholders' equity plus mezzanine Series A Preferred Shares and the deferred retroactive reinsurance gain less goodwill and intangible assets, net of amortization. Tangible equity per share represents tangible equity divided by the sum of total common shares outstanding plus the common shares resulting from an assumed conversion of the outstanding Series A Preferred Shares into common shares (at the conversion price effective as of the last day of the applicable period). Tangible common equity is defined as shareholders' equity plus the deferred retroactive reinsurance gain less goodwill and intangible assets, net of amortization. Tangible common equity per share represents tangible common equity divided by the total common shares outstanding. Our definitions of tangible equity, tangible equity per share, tangible common equity and tangible common equity per share may not be comparable to that of other companies, and they should not be viewed as a substitute for shareholders’ equity and shareholders’ equity per share calculated in accordance with GAAP.
The following table reconciles shareholders’ equity to tangible common equity as of June 30, 2025, December 31, 2024, and June 30, 2024:
June 30, 2025
December 31, 2024
June 30, 2024
($ in thousands, except share amounts)
Shareholders’ equity
$
492,558
$
460,915
$
541,791
Plus: Series A redeemable preferred shares
133,115
133,115
144,898
Plus: Deferred reinsurance gain
65,281
57,970
13,047
Less: Goodwill
181,831
181,831
181,831
Less: Intangible assets, net
32,268
32,450
32,631
Tangible equity
476,855
437,719
485,274
Less: Series A redeemable preferred shares
133,115
133,115
144,898
Tangible common equity
$
343,740
$
304,604
$
340,376
Common shares outstanding
45,895,335
45,644,318
37,825,767
Common shares from assumed conversion of Series A Preferred Shares
13,521,634
13,521,634
6,848,763
Common shares outstanding after assumed conversion of Series A Preferred Shares
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign currency exchange rates and commodity prices. Our consolidated balance sheets include assets and liabilities with estimated fair values that are subject to market risk. Our primary market risks have been interest rate risk associated with investments in fixed maturities and equity price risk associated with investments in equity securities. We do not have material exposure to foreign currency exchange rate risk or commodity risk.
There have been no material changes in market risk from the information provided in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure. In connection with the preparation of this quarterly report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of our CEO and CFO, as of June 30, 2025, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of June 30, 2025.
Changes in Internal Controls over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during our quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
The effectiveness of any system of controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that our controls and procedures will detect all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be attained.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The information required with respect to this item can be found under “Contingent Liabilities - Legal Proceedings” in note 8 of the notes to the unaudited consolidated financial statements contained in this quarterly report and is incorporated by reference into this Item 1.
Item 1A. Risk Factors
There have been no material changes in our risk factors in the quarter ended June 30, 2025 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document in Exhibit 101.
* Denotes a management contract or compensatory plan or arrangement.
+ Pursuant to Item 601(a)(5) of Regulation S-K, the Schedules to this Exhibit have been omitted. A copy of the omitted schedules will be furnished to the Securities and Exchange Commission upon request.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Customers and Suppliers of James River Group Holdings, Ltd.
Beta
No Customers Found
No Suppliers Found
Bonds of James River Group Holdings, Ltd.
Price Graph
Price
Yield
Insider Ownership of James River Group Holdings, Ltd.
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of James River Group Holdings, Ltd.
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)